<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.science.org/doi/10.1126/scitranslmed.abg6986');</script>

        <script> var body_html = '<body > <div > <div > <div > <div > <div > <div > <div > <div > <div > <div > <span >Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header > <div ><div ><div ><div ><div ><div ><div ><a ><div >science</div></a></div></div><div ><div ><a ><div >science advances</div></a></div></div><div ><div ><a ><div >science immunology</div></a></div></div><div ><div ><a ><div >science robotics</div></a></div></div><div ><div ><a ><div >science signaling</div></a></div></div><div ><div ><a ><div >science translational medicine</div></a></div></div><div ><div ><a ><div >science partner journals</div></a></div></div></div></div></div></div></div> <div > <div > <div > <div > <div ><div ><div ><label >Searching:</label><div ><div ><div ><a >Anywhere</a><a >Science</a><a >Science Advances</a><a >Science Immunology</a><a >Science Robotics</a><a >Science Signaling</a><a >Science Translational Medicine</a></div></div></div></div><div > <a ><u>Advanced Search</u></a> </div></div></div> </div> </div> </div> <div > <div > <div > <h6 >Trending Terms:</h6> <ul > <li > <a >covid-19</a> </li> <li > <a >climate</a> </li> <li > <a >science policy</a> </li> <li > <a >genome editing</a> </li> <li > <a >batteries</a> </li> </ul> </div> </div> </div> </div> </header><div ><div ><div > <div > <div > <ul > <li > <a >Current Issue</a> </li> <li > <a >First release papers</a> </li> <li > <a >Archive</a> </li> <li > <div > <a >About</a> <div > <a >About Science Translational Medicine</a> <a >Mission Scope</a> <a >Editors and Advisory Boards</a> <a >Editorial Policies</a> <a >Information for Authors</a> <a >Information for Reviewers</a> <a >Journal Metrics</a> <a >Staff</a> <a >Contact Us</a> <a >Subscribe</a> <a >Free Sample Articles</a> </div> </div> </li> </ul> </div> <div > <ul > <li > <a >Submit manuscript</a> </li> <li > <div > <a >More</a> </div> </li> </ul> </div> </div> <a >GET OUR E-ALERTS</a> </div></div></div> <main > <div ><div ><div ><div ><div > <div ><a >Home</a><a >Science Translational Medicine</a><a >Vol. 13, No. 625</a>A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</div><div >Back To Vol. 13, No. 625</div> </div> <article ><section ><header><div ><div ><div ><div >Research Article</div><div >CANCER</div></div><div ><div > <div >Share on</div> </div></div></div><h1 >A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</h1><div >Qian Zhang https://orcid.org/0000-0002-2858-0962, Morgan E. Hresko https://orcid.org/0000-0003-1322-3791, Lora K. Picton https://orcid.org/0000-0002-0482-5187, Leon Su https://orcid.org/0000-0001-7654-9997, Michael J. Hollander https://orcid.org/0000-0002-3108-2788, Selene Nunez-Cruz, Zheng Zhang https://orcid.org/0000-0002-3242-5738, Charles-Antoine Assenmacher https://orcid.org/0000-0003-0073-2730, Jonathan T. Sockolosky https://orcid.org/0000-0002-5441-1409, K. Christopher Garcia https://orcid.org/0000-0001-9273-0278 [email protected], and Michael C. Milone https://orcid.org/0000-0002-1580-9844 [email protected]</div><div >Science Translational Medicine • 22 Dec 2021 • Vol 13, Issue 625 • DOI: 10.1126/scitranslmed.abg6986</div><div ><div > <div > <a ><div ><div ><h6>PREVIOUS ARTICLE</h6><div>Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics</div></div></div>Previous</a><a ><div ><div ><h6>NEXT ARTICLE</h6><div>An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</div></div></div>Next</a> </div> </div><div ><div >get access</div></div></div><section ><div ><div ><div >Related Research Article</div><div ><h6 >An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h6></div></div></div></section></div></header><div ><div ><section ><h2 >An orthogonal approach to cancer</h2><div >Interleukin-2 (IL-2) is an important cytokine for T cell activation and has been considered as a treatment for cancer. However, systemic administration of IL-2 often leads to severe toxicity. To address this, Zhang <i>et al.</i> and Aspuria <i>et al.</i> engineered T cells to express an IL-2 receptor β (IL-2Rβ) that can only be activated by a modified, orthogonal IL-2. Orthogonal IL-2Rβ was introduced to CAR T cells targeting CD19, and the CAR T cells were transferred to mice bearing leukemias or lymphomas. Administration of orthogonal IL-2 to CAR T cell recipients drove activation, expansion, and antitumor efficacy of CAR T cells in both preclinical models with limited systemic toxicity. Thus, orthogonal cytokine-receptor pairs may offer a safer approach to enhance adoptive cell therapy.</div></section><section ><h2 >Abstract</h2><div >Interleukin-2 (IL-2) is a central T cell cytokine that promotes T cell proliferation and effector function; however, toxicity due to its pluripotency limits its application to enhance CAR T cell immunotherapy. Previously, mouse IL-2 and its cognate receptor were engineered to create an orthogonal (<i>ortho</i>) cytokine-cytokine receptor pair capable of delivering an IL-2 signal without toxicity. Here, we engineered a human orthogonal IL-2 (<i>ortho-</i>hIL-2) and human orthogonal IL-2Rβ (<i>ortho-</i>hIL-2Rβ) pair, containing human-specific mutations. <i>Ortho-</i>hIL-2 is selective toward <i>ortho-</i>hIL-2Rβ–expressing cells with no appreciable signaling on wild-type T cells. <i>Ortho-</i>hIL-2 induces IL-2 receptor signaling and supports proliferation of both an IL-2–dependent cell line and primary T cells transduced to express the <i>ortho-</i>hIL-2Rβ. Using CD19-specific chimeric antigen receptor (CAR) T cells, we show that <i>ortho</i>-hIL-2 induces a dose-dependent increase in <i>ortho</i>-hIL-2Rβ<sup>+</sup> CAR T cell expansion in vivo by as much as 1000-fold at 2 weeks after adoptive transfer into immunodeficient mice bearing CD19<sup>+</sup> Nalm6 leukemia xenografts. <i>Ortho</i>-hIL-2 can rescue the antileukemic effect of an otherwise suboptimal CAR T cell dose. In addition, <i>ortho</i>-hIL-2 administration initiated at the time of leukemic relapse after CAR T cell therapy can rescue an otherwise failed antileukemic response. These data highlight the potential of combining an orthogonal cytokine approach with T cell–based immunotherapies to augment the antitumor efficacy of engineered T cells.</div></section></div></div></section><section ><div ><div><div ><h5 >Get full access to this article</h5><p >View all available purchase options and get full access to this article.</p><div ><a > Get Access</a></div><div >Already a Subscriber?Sign In</div></div></div></div></section><section ><div ><section ><h2>Supplementary Materials</h2><section ><h3>This PDF file includes:</h3><div ><div ><div>Figs. S1 to S13</div><div>Table S1</div></div><div ><a >Download (1.56 MB)</a></div></div></section><section ><h3>Other Supplementary Material for this manuscript includes the following:</h3><div ><div ><div>Data File S1</div></div><div ><a >Download (100.23 KB)</a></div></div></section></section><div ><a >View/request a protocol for this paper from <i>Bio-protocol</i>.</a></div><section ><h2>REFERENCES AND NOTES</h2><div ><div >1</div><div ><div ><div >C. H. June, R. S. O’Connor, O. U. Kawalekar, S. Ghassemi, M. C. Milone, CAR T cell immunotherapy for human cancer. Science <b>359</b>, 1361–1365 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >2</div><div ><div ><div >J. N. Kochenderfer, M. E. Dudley, S. H. Kassim, R. P. Somerville, R. O. Carpenter, M. Stetler-Stevenson, J. C. Yang, G. Q. Phan, M. S. Hughes, R. M. Sherry, M. Raffeld, S. Feldman, L. Lu, Y. F. Li, L. T. Ngo, A. Goy, T. Feldman, D. E. Spaner, M. L. Wang, C. C. Chen, S. M. Kranick, A. Nath, D.-A. N. Nathan, K. E. Morton, M. A. Toomey, S. A. Rosenberg, Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J. Clin. Oncol. <b>33</b>, 540–549 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >3</div><div ><div ><div >S. L. Maude, T. W. Laetsch, J. Buechner, S. Rives, M. Boyer, H. Bittencourt, P. Bader, M. R. Verneris, H. E. Stefanski, G. D. Myers, M. Qayed, B. De Moerloose, H. Hiramatsu, K. Schlis, K. L. Davis, P. L. Martin, E. R. Nemecek, G. A. Yanik, C. Peters, A. Baruchel, N. Boissel, F. Mechinaud, A. Balduzzi, J. Krueger, C. H. June, B. L. Levine, P. Wood, T. Taran, M. Leung, K. T. Mueller, Y. Zhang, K. Sen, D. Lebwohl, M. A. Pulsipher, S. A. Grupp, Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. <b>378</b>, 439–448 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >4</div><div ><div ><div >D. L. Porter, W.-T. Hwang, N. V. Frey, S. F. Lacey, P. A. Shaw, A. W. Loren, A. Bagg, K. T. Marcucci, A. Shen, V. Gonzalez, D. Ambrose, S. A. Grupp, A. Chew, Z. Zheng, M. C. Milone, B. L. Levine, J. J. Melenhorst, C. H. June, Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci. Transl. Med. <b>7</b>, 303ra139 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >5</div><div ><div ><div >S. J. Schuster, M. R. Bishop, C. S. Tam, E. K. Waller, P. Borchmann, J. P. McGuirk, U. Jäger, S. Jaglowski, C. Andreadis, J. R. Westin, I. Fleury, V. Bachanova, S. R. Foley, P. J. Ho, S. Mielke, J. M. Magenau, H. Holte, S. Pantano, L. B. Pacaud, R. Awasthi, J. Chu, Ö. Anak, G. Salles, R. T. Maziarz, Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N. Engl. J. Med. <b>380</b>, 45–56 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >6</div><div ><div ><div >F. L. Locke, A. Ghobadi, C. A. Jacobson, D. B. Miklos, L. J. Lekakis, O. O. Oluwole, Y. Lin, I. Braunschweig, B. T. Hill, J. M. Timmerman, A. Deol, P. M. Reagan, P. Stiff, I. W. Flinn, U. Farooq, A. Goy, P. A. McSweeney, J. Munoz, T. Siddiqi, J. C. Chavez, A. F. Herrera, N. L. Bartlett, J. S. Wiezorek, L. Navale, A. Xue, Y. Jiang, A. Bot, J. M. Rossi, J. J. Kim, W. Y. Go, S. S. Neelapu, Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): A single-arm, multicentre, phase 1-2 trial. Lancet Oncol. <b>20</b>, 31–42 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >7</div><div ><div ><div >N. Raje, J. Berdeja, Y. Lin, D. Siegel, S. Jagannath, D. Madduri, M. Liedtke, J. Rosenblatt, M. V. Maus, A. Turka, L.-P. Lam, R. A. Morgan, K. Friedman, M. Massaro, J. Wang, G. Russotti, Z. Yang, T. Campbell, K. Hege, F. Petrocca, M. T. Quigley, N. Munshi, J. N. Kochenderfer, Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma. N. Engl. J. Med. <b>380</b>, 1726–1737 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >8</div><div ><div ><div >A. D. Cohen, A. L. Garfall, E. A. Stadtmauer, J. J. Melenhorst, S. F. Lacey, E. Lancaster, D. T. Vogl, B. M. Weiss, K. Dengel, A. Nelson, G. Plesa, F. Chen, M. M. Davis, W.-T. Hwang, R. M. Young, J. L. Brogdon, R. Isaacs, I. Pruteanu-Malinici, D. L. Siegel, B. L. Levine, C. H. June, M. C. Milone, B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma. J. Clin. Invest. <b>129</b>, 2210–2221 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >9</div><div ><div ><div >J. A. Fraietta, S. F. Lacey, E. J. Orlando, I. Pruteanu-Malinici, M. Gohil, S. Lundh, A. C. Boesteanu, Y. Wang, R. S. O’Connor, W.-T. Hwang, E. Pequignot, D. E. Ambrose, C. Zhang, N. Wilcox, F. Bedoya, C. Dorfmeier, F. Chen, L. Tian, H. Parakandi, M. Gupta, R. M. Young, F. B. Johnson, I. Kulikovskaya, L. Liu, J. Xu, S. H. Kassim, M. M. Davis, B. L. Levine, N. V. Frey, D. L. Siegel, A. C. Huang, E. J. Wherry, H. Bitter, J. L. Brogdon, D. L. Porter, C. H. June, J. J. Melenhorst, Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat. Med. <b>24</b>, 563–571 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >10</div><div ><div ><div >E. Sotillo, D. M. Barrett, K. L. Black, A. Bagashev, D. Oldridge, G. Wu, R. Sussman, C. Lanauze, M. Ruella, M. R. Gazzara, N. M. Martinez, C. T. Harrington, E. Y. Chung, J. Perazzelli, T. J. Hofmann, S. L. Maude, P. Raman, A. Barrera, S. Gill, S. F. Lacey, J. J. Melenhorst, D. Allman, E. Jacoby, T. Fry, C. Mackall, Y. Barash, K. W. Lynch, J. M. Maris, S. A. Grupp, A. Thomas-Tikhonenko, Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy. Cancer Discov. <b>5</b>, 1282–1295 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >11</div><div ><div ><div >S. A. Rosenberg, IL-2: The first effective immunotherapy for human cancer. J. Immunol. <b>192</b>, 5451–5458 (2014).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >12</div><div ><div ><div >L. A. Matis, S. Shu, E. S. Groves, S. Zinn, T. Chou, A. M. Kruisbeek, M. Rosenstein, S. A. Rosenberg, Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: Correlation with clonal IL 2 receptor expression. J. Immunol. <b>136</b>, 3496–3501 (1986).</div><div ><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >13</div><div ><div ><div >M. J. Besser, R. Shapira-Frommer, O. Itzhaki, A. J. Treves, D. B. Zippel, D. Levy, A. Kubi, N. Shoshani, D. Zikich, Y. Ohayon, D. Ohayon, B. Shalmon, G. Markel, R. Yerushalmi, S. Apter, A. Ben-Nun, E. Ben-Ami, A. Shimoni, A. Nagler, J. Schachter, Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: Intent-to-treat analysis and efficacy after failure to prior immunotherapies. Clin. Cancer Res. <b>19</b>, 4792–4800 (2013).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >14</div><div ><div ><div >J. P. Dutcher, Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma. Oncology <b>16</b>, 4–10 (2002).</div><div ><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >15</div><div ><div ><div >P. Dhupkar, N. Gordon, Interleukin-2: Old and new approaches to enhance immune-therapeutic efficacy. Adv. Exp. Med. Biol. <b>995</b>, 33–51 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >16</div><div ><div ><div >M. B. Atkins, J. Sparano, R. I. Fisher, G. R. Weiss, K. A. Margolin, K. I. Fink, L. Rubinstein, A. Louie, J. W. Mier, R. Gucalp, Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma. J. Clin. Oncol. <b>11</b>, 661–670 (1993).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >17</div><div ><div ><div >M. B. Atkins, M. T. Lotze, J. P. Dutcher, R. I. Fisher, G. Weiss, K. Margolin, J. Abrams, M. Sznol, D. Parkinson, M. Hawkins, C. Paradise, L. Kunkel, S. A. Rosenberg, High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993. J. Clin. Oncol. <b>17</b>, 2105–2116 (1999).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >18</div><div ><div ><div >G. Fyfe, R. I. Fisher, S. A. Rosenberg, M. Sznol, D. R. Parkinson, A. C. Louie, Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J. Clin. Oncol. <b>13</b>, 688–696 (1995).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >19</div><div ><div ><div >U. S. Kammula, D. E. White, S. A. Rosenberg, Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer. Cancer <b>83</b>, 797–805 (1998).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >20</div><div ><div ><div >J. T. Sockolosky, E. Trotta, G. Parisi, L. Picton, L. L. Su, A. C. Le, A. Chhabra, S. L. Silveria, B. M. George, I. C. King, M. R. Tiffany, K. Jude, L. V. Sibener, D. Baker, J. A. Shizuru, A. Ribas, J. A. Bluestone, K. Christopher Garcia, Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science <b>359</b>, 1037–1042 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >21</div><div ><div ><div >K. Kaltoft, S. Bisballe, H. F. Rasmussen, K. Thestrup-Pedersen, K. Thomsen, W. Sterry, A continuous T-cell line from a patient with Sézary syndrome. Arch. Dermatol. Res. <b>279</b>, 293–298 (1987).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >22</div><div ><div ><div >N. Arenas-Ramirez, J. Woytschak, O. Boyman, Interleukin-2: Biology, design and application. Trends Immunol. <b>36</b>, 763–777 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >23</div><div ><div ><div >J. Eyquem, J. Mansilla-Soto, T. Giavridis, S. J. van der Stegen, M. Hamieh, K. M. Cunanan, A. Odak, M. Gönen, M. Sadelain, Targeting a CAR to the <i>TRAC</i> locus with CRISPR/Cas9 enhances tumour rejection. Nature <b>543</b>, 113–117 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >24</div><div ><div ><div >E. Wang, L. C. Wang, C. Y. Tsai, V. Bhoj, Z. Gershenson, E. Moon, K. Newick, J. Sun, A. Lo, T. Baradet, M. D. Feldman, D. Barrett, E. Puré, S. Albelda, M. C. Milone, Generation of potent T-cell immunotherapy for cancer using DAP12-based, multichain, chimeric immunoreceptors. Cancer Immunol. Res. <b>3</b>, 815–826 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >25</div><div ><div ><div >D. M. Barrett, Y. Zhao, X. Liu, S. Jiang, C. Carpenito, M. Kalos, R. G. Carroll, C. H. June, S. A. Grupp, Treatment of advanced leukemia in mice with mRNA engineered T cells. Hum. Gene Ther. <b>22</b>, 1575–1586 (2011).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >26</div><div ><div ><div >J. G. Pol, P. Caudana, J. Paillet, E. Piaggio, G. Kroemer, Effects of interleukin-2 in immunostimulation and immunosuppression. J. Exp. Med. <b>217</b>, e20191247 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >27</div><div ><div ><div >A. V. Hirayama, J. Gauthier, K. A. Hay, J. M. Voutsinas, Q. Wu, T. Gooley, D. Li, S. Cherian, X. Chen, B. S. Pender, R. M. Hawkins, A. Vakil, R. N. Steinmetz, U. H. Acharya, R. D. Cassaday, A. G. Chapuis, T. M. Dhawale, P. C. Hendrie, H. P. Kiem, R. C. Lynch, J. Ramos, M. Shadman, B. G. Till, S. R. Riddell, D. G. Maloney, C. J. Turtle, The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. Blood <b>133</b>, 1876–1887 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >28</div><div ><div ><div >C. A. Klebanoff, L. Gattinoni, D. C. Palmer, P. Muranski, Y. Ji, C. S. Hinrichs, Z. A. Borman, S. P. Kerkar, C. D. Scott, S. E. Finkelstein, S. A. Rosenberg, N. P. Restifo, Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice. Clin. Cancer Res. <b>17</b>, 5343–5352 (2011).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >29</div><div ><div ><div >C. A. Klebanoff, H. T. Khong, P. A. Antony, D. C. Palmer, N. P. Restifo, Sinks, suppressors and antigen presenters: How lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol. <b>26</b>, 111–117 (2005).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >30</div><div ><div ><div >P. Muranski, A. Boni, C. Wrzesinski, D. E. Citrin, S. A. Rosenberg, R. Childs, N. P. Restifo, Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go? Nat. Clin. Pract. Oncol. <b>3</b>, 668–681 (2006).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >31</div><div ><div ><div >G. C. Sim, L. Radvanyi, The IL-2 cytokine family in cancer immunotherapy. Cytokine Growth Factor Rev. <b>25</b>, 377–390 (2014).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >32</div><div ><div ><div >C. Pearson, A. Silva, M. Saini, B. Seddon, IL-7 determines the homeostatic fitness of T cells by distinct mechanisms at different signalling thresholds in vivo. Eur. J. Immunol. <b>41</b>, 3656–3666 (2011).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >33</div><div ><div ><div >F. Melchionda, T. J. Fry, M. J. Milliron, M. A. McKirdy, Y. Tagaya, C. L. Mackall, Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J. Clin. Invest. <b>115</b>, 1177–1187 (2005).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >34</div><div ><div ><div >N. L. Alves, B. Hooibrink, F. A. Arosa, R. A. W. van Lier, IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood <b>102</b>, 2541–2546 (2003).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >35</div><div ><div ><div >N. Frey, D. Porter, Cytokine release syndrome with chimeric antigen receptor T cell therapy. Biol. Blood Marrow Transplant. <b>25</b>, e123–e127 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >36</div><div ><div ><div >T. Giavridis, S. J. C. van der Stegen, J. Eyquem, M. Hamieh, A. Piersigilli, M. Sadelain, CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat. Med. <b>24</b>, 731–738 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >37</div><div ><div ><div >M. Norelli, B. Camisa, G. Barbiera, L. Falcone, A. Purevdorj, M. Genua, F. Sanvito, M. Ponzoni, C. Doglioni, P. Cristofori, C. Traversari, C. Bordignon, F. Ciceri, R. Ostuni, C. Bonini, M. Casucci, A. Bondanza, Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat. Med. <b>24</b>, 739–748 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >38</div><div ><div ><div >M. E. Pipkin, J. A. Sacks, F. Cruz-Guilloty, M. G. Lichtenheld, M. J. Bevan, A. Rao, Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity <b>32</b>, 79–90 (2010).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >39</div><div ><div ><div >K. Lorre, L. Fransen, J. L. Ceuppens, Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway. Eur. Cytokine Netw. <b>3</b>, 321–330 (1992).</div><div ><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >40</div><div ><div ><div >A. Ythier, M. P. Gascon, P. Juillard, C. Vesin, D. Wallach, G. E. Grau, Protective effect of natural TNF-binding protein on human TNF-induced toxicity in mice. Cytokine <b>5</b>, 459–462 (1993).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >41</div><div ><div ><div >P. Strati, S. Ahmed, P. Kebriaei, L. I. Nastoupil, C. M. Claussen, G. Watson, S. B. Horowitz, A. R. T. Brown, B. Do, M. A. Rodriguez, R. Nair, E. J. Shpall, M. R. Green, S. S. Neelapu, J. R. Westin, Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma. Blood Adv. <b>4</b>, 3123–3127 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >42</div><div ><div ><div >S. L. Maude, D. Barrett, D. T. Teachey, S. A. Grupp, Managing cytokine release syndrome associated with novel T cell-engaging therapies. Cancer J. <b>20</b>, 119–122 (2014).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >43</div><div ><div ><div >C. Waugh, L. Sinclair, D. Finlay, J. R. Bayascas, D. Cantrell, Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation. Mol. Cell. Biol. <b>29</b>, 5952–5962 (2009).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >44</div><div ><div ><div >V. Mirenda, S. J. Jarmin, R. David, J. Dyson, D. Scott, Y. Gu, R. I. Lechler, K. Okkenhaug, F. M. Marelli-Berg, Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood <b>109</b>, 2968–2977 (2007).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >45</div><div ><div ><div >J. N. Blattman, J. M. Grayson, E. J. Wherry, S. M. Kaech, K. A. Smith, R. Ahmed, Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. <b>9</b>, 540–547 (2003).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >46</div><div ><div ><div >P. J. Aspuria, S. Vivona, M. Bauer, M. Semana, N. Ratti, S. M. Cauley, R. Riener, R. de Waal Malefyt, D. Rokkam, J. Emmerich, R. A. Kastelein, P. J. Lupardus, M. Oft, An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma. Sci. Transl. Med. <b>13</b>, eabg7565 (2021).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >47</div><div ><div ><div >M. C. Milone, J. D. Fish, C. Carpenito, R. G. Carroll, G. K. Binder, D. Teachey, M. Samanta, M. Lakhal, B. Gloss, G. Danet-Desnoyers, D. Campana, J. L. Riley, S. A. Grupp, C. H. June, Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther. <b>17</b>, 1453–1464 (2009).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >48</div><div ><div ><div >G. Chao, W. L. Lau, B. J. Hackel, S. L. Sazinsky, S. M. Lippow, K. D. Wittrup, Isolating and engineering human antibodies using yeast surface display. Nat. Protoc. <b>1</b>, 755–768 (2006).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >49</div><div ><div ><div >J. Bryant, R. Day, T. L. Whiteside, R. B. Herberman, Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Methods <b>146</b>, 91–103 (1992).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >50</div><div ><div ><div >B. Kittel, C. Ruehl-Fehlert, G. Morawietz, J. Klapwijk, M. R. Elwell, B. Lenz, M. G. O’Sullivan, D. R. Roth, P. F. Wadsworth, Revised guides for organ sampling and trimming in rats and mice—Part 2. A joint publication of the RITA and NACAD groups. Exp. Toxicol. Pathol. <b>55</b>, 413–431 (2004).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >51</div><div ><div ><div >G. Morawietz, C. Ruehl-Fehlert, B. Kittel, A. Bube, K. Keane, S. Halm, A. Heuser, J. Hellmann, Revised guides for organ sampling and trimming in rats and mice—Part 3. A joint publication of the RITA and NACAD groups. Exp. Toxicol. Pathol. <b>55</b>, 433–449 (2004).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >52</div><div ><div ><div >C. Ruehl-Fehlert, B. Kittel, G. Morawietz, P. Deslex, C. Keenan, C. R. Mahrt, T. Nolte, M. Robinson, B. P. Stuart, U. Deschl, Revised guides for organ sampling and trimming in rats and mice—Part 1: A joint publication of the RITA and NACAD groups. Exp. Toxicol. Pathol. <b>55</b>, 91–106 (2003).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div></section></div></section><div ><div ><header><h2>Information Authors</h2></header><section ><h3>Information</h3><section ><h4>Published In</h4><div > <div ><div >Science Translational Medicine</div><div >Volume 13 | Issue 625December 2021</div></div></div></section><section ><h4>Copyright</h4><div >Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</div><div >https://www.sciencemag.org/about/science-licenses-journal-article-reuse</div><div >This is an article distributed under the terms of the Science Journals Default License.</div></section><section ><h4>Submission history</h4><div><b >Received</b>: 22 January 2021</div><div><b >Accepted</b>: 14 October 2021</div></section><section ><h4>Permissions</h4><div>Request permissions for this article.</div><div><a >Request Permissions</a></div></section><section ><h4>Acknowledgments</h4><div >We thank the members of the following facilities at the University of Pennsylvania: the Flow Cytometry Core for cell sorting, the Human Immunology Core for providing T cells from normal donors, the Translational and Correlative Studies Laboratory for performing Luminex Assays, the Laboratory Animal Resources, the Stem Cell and Xenograft Core for the tumor and CAR T cell injections and drawing blood from mice, and the Comparative Pathology Core for immunohistochemistry, image acquisition, and analysis. We thank M. A. Wasik in the Fox Chase Cancer Center for providing SeAx cells. We also thank F. Lang, J. Leferovich, and J. Han Noll for assistance with in the vivo experiments.</div><div ><b>Funding:</b> The research reported in this publication was supported by grants from NIH National Cancer Institute (U54CA244711 to M.C.M. and K.C.G.) and institutional funds of the University of Pennsylvania. The Penn Vet Comparative Pathology Core is supported by the Abramson Cancer Center Support Grant (P30 CA016520). The scanner used for whole slide imaging was supported by an NIH Shared Instrumentation Grant (S10 OD023465-01A1 to the Penn Vet Comparative Pathology Core). K.C.G. is an Investigator of the Howard Hughes Medical Institute and supported by Ludwig Foundation and Parker Institute for Cancer Immunotherapy (U54CA244711 and RO1-AI51321).</div><div ><b>Author contributions:</b> Q.Z. designed the project, oversaw and performed the experiments, analyzed the data, and wrote the manuscript. M.E.H., L.K.P., L.S., J.T.S., M.J.H., and J.T.S. conducted and analyzed the in vitro and in vivo experiments and data. K.C.G. and J.T.S. designed the <i>ortho</i>-IL-2/<i>ortho</i>-IL-2Rβ system and provided human <i>ortho-</i>IL-2. L.S. performed in vitro functional characterization of the <i>ortho</i>-IL-2/<i>ortho</i>-IL-2Rβ system. L.K.P. provided recombinant <i>ortho</i>-IL-2 for in vivo studies. S.N.-C. helped in vivo experiments. Z.Z. performed in vivo experiments. M.C.M. conceived and designed the study, oversaw the project, and contributed to data analysis and editing of the final version of the manuscript. All authors approved the final version of the manuscript.</div><div ><b>Competing interests:</b> M.C.M. is an inventor of CAR T cell technology used in these studies (Methods for treatment of cancer, U.S. patent no. 8,906,682). This technology is owned by the University of Pennsylvania and licensed to Novartis AG. K.C.G. is the Founder of Synthekine Therapeutics, which has licensed the ortho-2 technology. K.C.G., J.T.S., L.S., and L.K.P. are inventors on a patent application describing the ortho-2 system (Biologically relevant orthogonal cytokine/receptor pairs, U.S. patent no. 10,869,887B2). K.C.G., J.T.S., L.S., and L.K.P. are shareholders of Synthekine, a biotechnology company that has licensed the <i>ortho-</i>IL-2 technology. The remaining authors declare no competing financial interests.</div><div ><b>Data and materials availability:</b> All data associated with this study are present in the paper or the Supplementary Materials. A material transfer agreement will be required for the sharing of materials used in these studies. Requests for materials should be sent to either M.C.M. (<a >[email protected]</a>) or K.C.G. (<a >[email protected]</a>).</div></section></section><section ><h3>Authors</h3><section ><h4>Affiliations</h4><div ><div >Qian Zhang https://orcid.org/0000-0002-2858-0962</div><div ><div ><div >Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Morgan E. Hresko https://orcid.org/0000-0003-1322-3791</div><div ><div ><div >Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Lora K. Picton https://orcid.org/0000-0002-0482-5187</div><div ><div ><div >Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Leon Su https://orcid.org/0000-0001-7654-9997</div><div ><div ><div >Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Michael J. Hollander https://orcid.org/0000-0002-3108-2788</div><div ><div ><div >Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Selene Nunez-Cruz</div><div ><div ><div >Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Zheng Zhang https://orcid.org/0000-0002-3242-5738</div><div ><div ><div >Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Charles-Antoine Assenmacher https://orcid.org/0000-0003-0073-2730</div><div ><div ><div >Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Jonathan T. Sockolosky https://orcid.org/0000-0002-5441-1409</div><div ><div ><div >Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div ><div >Present address: Department of Antibody Engineering, Genentech Inc., 1 DNA Way, South San Francisco, CA 94090, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >K. Christopher Garcia<sup >*</sup> https://orcid.org/0000-0001-9273-0278 [email protected]</div><div ><div ><div >Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div><div >Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Michael C. Milone<sup >*</sup> https://orcid.org/0000-0002-1580-9844 [email protected]</div><div ><div ><div >Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div >View all articles by this author</div></div></div></section><section ><h4>Funding Information</h4><div >National Institutes of Health: U54CA244711</div><div ><a >National Institutes of Health</a>: S10 OD023465-01A1</div><div ><a >National Institutes of Health</a>: </div><div ><a >Howard Hughes Medical Institute</a>: U54CA244711</div><div ><a >Howard Hughes Medical Institute</a>: RO1-AI51321</div><div ><a >University of Pennsvlvania</a>: </div><div ><a >University of Pennsvlvania</a>: S10 OD023465-01A1</div><div ><a >Parker Institute for Cancer Immunotherapy</a>: </div><div ><a >Parker Institute for Cancer Immunotherapy</a>: U54CA244711</div><div ><a >Parker Institute for Cancer Immunotherapy</a>: RO1-AI51321</div><div ><a >UVA Cancer Center</a>: </div><div ><a >Cancer Center, University of Florida Health</a>: P30 CA016520</div><div ><a >Cancer Center, University of Florida Health</a>: </div><div >NIH National Cancer Institute and institutional funds of the University of Pennsylvania: U54CA244711</div><div ><a >UVA Cancer Center</a>: P30 CA016520</div></section><section ><h4>Notes</h4><div >*Corresponding author. Email: <a >[email protected]</a> (M.C.M.); <a >[email protected]</a> (K.C.G.)</div></section></section></div><div ><header><h2>Metrics Citations</h2></header><section ><h3>Metrics</h3><section > <h5 > Article Usage </h5> </section><section > <h5 > Altmetrics </h5> </section></section><section ><h3>Citations</h3><section > <div > <h5 >Export citation</h5> <p>Select the format you want to export the citation of this publication.</p> </div> </section></section></div><div ><header><h2>View Options</h2></header><div ><h3>Get Access</h3><section > <div ><h5>Log in to view the full text</h5> <p><a >AAAS Log in</a></p> <p>AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul > <li >Become a AAAS Member</li> <li ><a >Activate your Account</a></li> <li ><a >Purchase Access to Other Journals in the Science Family</a></li> <li><a >Account Help</a></li> </ul> <div > <div >Log in via OpenAthens. <div ><a >via OpenAthens</a></div> </div> <div >Log in via Shibboleth. <div ><a >via Shibboleth</a></div> </div> </div> </div> <div ><h4>More options</h4><p><a >Purchase digital access to this article</a></p><p >Download and print this article for your personal scholarly, research, and educational use.</p></div> </section></div><div ><h3>View options</h3><section ><h4>PDF format</h4><p>Download this article as a PDF file</p><a >Download PDF</a></section></div></div><div ><header><h2>Media</h2></header><section ><h3>Figures</h3></section><section ><h3>Multimedia</h3></section></div><div ><header><h2>Tables</h2></header></div><div ><header><h2>Share</h2></header><h3>Share</h3><div ><section ><h4>Share article link</h4><div ><a >Copy Link</a><div ><p >Copied!</p><p >Copying failed.</p></div></div></section><section ><h4>Share on social media</h4><div ><a >facebook</a><a >twitter</a><a >linkedin</a><a >email</a></div></section></div></div></div></article><section ><div ><div ><div ><div ><h3 >Submit a Response to This Article</h3></div></div></div></div> <div > <div > <h2 >(0)eLetters</h2> </div> <p >eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> Log In to Submit a Response <p >No eLetters have been published for this article yet.</p> </div> </section> <div ><a >View Full Text</a><a >Download PDF</a></div> </div></div></div></div><div ><div ><div ><div ><section><div ><h4 > Current Issue </h4><div ><div > <div ><div><article ><div ><div ><h3 ><a >Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics</a></h3><ul ><li >By<ul > <li >Jay-Hyun Jo</li> <li >Catriona P. Harkins</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</h3><ul ><li >By<ul > <li >Qian Zhang</li> <li >Morgan E. Hresko</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h3><ul ><li >By<ul > <li >Paul-Joseph Aspuria</li> <li >Sandro Vivona</li> <li >et al.</li> </ul> </li></ul></div></div></article></div><div >Table of Contents</div></div> </div></div></div></section><section > <h4 >LATEST NEWS</h4> <div > <div ><div > <article > <div > <div > News<time >30 Dec 2021</time> </div> <div > Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article > <div > <div > ScienceInsider<time >29 Dec 2021</time> </div> <div > <a > Once a ‘crazy idea,’ patent-pooling nonprofit will help bring COVID-19 pills to world’s poor </a> </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > The natural world loses two of its biggest advocates </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > <a > What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article > <div > <div > ScienceInsider<time >25 Dec 2021</time> </div> <div > NASA’s Webb telescope takes flight—a Christmas gift to astronomers everywhere </div> </div> </article> <article > <div > <div > News<time >23 Dec 2021</time> </div> <div > <a > More than a virus: Science’s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <div class="valid" valid="valid" title="valid: True, node: 5, tag: div, level: 5" node_number="5"> <div class="valid" valid="valid" title="valid: True, node: 6, tag: div, level: 6" node_number="6"> <div class="valid" valid="valid" title="valid: True, node: 7, tag: div, level: 7" node_number="7"> <div class="valid" valid="valid" title="valid: True, node: 8, tag: div, level: 8" node_number="8"> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 9" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 10" node_number="10"> <div class="valid" valid="valid" title="valid: True, node: 11, tag: div, level: 11" node_number="11"> <span class="valid" valid="valid" title="valid: True, node: 12, tag: span, level: 12" node_number="12">Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header class="valid" valid="valid" title="valid: True, node: 13, tag: header, level: 5" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 6" node_number="14"><div class="valid" valid="valid" title="valid: True, node: 15, tag: div, level: 7" node_number="15"><div class="valid" valid="valid" title="valid: True, node: 16, tag: div, level: 8" node_number="16"><div class="valid" valid="valid" title="valid: True, node: 17, tag: div, level: 9" node_number="17"><div class="valid" valid="valid" title="valid: True, node: 18, tag: div, level: 10" node_number="18"><div class="valid" valid="valid" title="valid: True, node: 19, tag: div, level: 11" node_number="19"><div class="valid" valid="valid" title="valid: True, node: 20, tag: div, level: 12" node_number="20"><a class="valid" valid="valid" title="valid: True, node: 21, tag: a, level: 13" node_number="21"><div class="valid" valid="valid" title="valid: True, node: 22, tag: div, level: 14" node_number="22">science</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 23, tag: div, level: 11" node_number="23"><div class="valid" valid="valid" title="valid: True, node: 24, tag: div, level: 12" node_number="24"><a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 13" node_number="25"><div class="valid" valid="valid" title="valid: True, node: 26, tag: div, level: 14" node_number="26">science advances</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 27, tag: div, level: 11" node_number="27"><div class="valid" valid="valid" title="valid: True, node: 28, tag: div, level: 12" node_number="28"><a class="valid" valid="valid" title="valid: True, node: 29, tag: a, level: 13" node_number="29"><div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 14" node_number="30">science immunology</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 11" node_number="31"><div class="valid" valid="valid" title="valid: True, node: 32, tag: div, level: 12" node_number="32"><a class="valid" valid="valid" title="valid: True, node: 33, tag: a, level: 13" node_number="33"><div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 14" node_number="34">science robotics</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 11" node_number="35"><div class="valid" valid="valid" title="valid: True, node: 36, tag: div, level: 12" node_number="36"><a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 13" node_number="37"><div class="valid" valid="valid" title="valid: True, node: 38, tag: div, level: 14" node_number="38">science signaling</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 39, tag: div, level: 11" node_number="39"><div class="valid" valid="valid" title="valid: True, node: 40, tag: div, level: 12" node_number="40"><a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 13" node_number="41"><div class="valid" valid="valid" title="valid: True, node: 42, tag: div, level: 14" node_number="42">science translational medicine</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 43, tag: div, level: 11" node_number="43"><div class="valid" valid="valid" title="valid: True, node: 44, tag: div, level: 12" node_number="44"><a class="valid" valid="valid" title="valid: True, node: 45, tag: a, level: 13" node_number="45"><div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 14" node_number="46">science partner journals</div></a></div></div></div></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 47, tag: div, level: 6" node_number="47"> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 7" node_number="48"> <div class="valid" valid="valid" title="valid: True, node: 49, tag: div, level: 8" node_number="49"> <div class="valid" valid="valid" title="valid: True, node: 50, tag: div, level: 9" node_number="50"> <div class="valid" valid="valid" title="valid: True, node: 51, tag: div, level: 10" node_number="51"><div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 11" node_number="52"><div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 12" node_number="53"><label class="valid" valid="valid" title="valid: True, node: 54, tag: label, level: 13" node_number="54">Searching:</label><div class="valid" valid="valid" title="valid: True, node: 55, tag: div, level: 13" node_number="55"><div class="valid" valid="valid" title="valid: True, node: 56, tag: div, level: 14" node_number="56"><div title="valid: False, node: 57, tag: div, level: 15" node_number="57"><a title="valid: False, node: 58, tag: a, level: 16" node_number="58">Anywhere</a><a title="valid: False, node: 59, tag: a, level: 16" node_number="59">Science</a><a title="valid: False, node: 60, tag: a, level: 16" node_number="60">Science Advances</a><a title="valid: False, node: 61, tag: a, level: 16" node_number="61">Science Immunology</a><a title="valid: False, node: 62, tag: a, level: 16" node_number="62">Science Robotics</a><a title="valid: False, node: 63, tag: a, level: 16" node_number="63">Science Signaling</a><a title="valid: False, node: 64, tag: a, level: 16" node_number="64">Science Translational Medicine</a></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 65, tag: div, level: 12" node_number="65"> <a class="valid" valid="valid" title="valid: True, node: 66, tag: a, level: 13" node_number="66"><u class="valid" valid="valid" title="valid: True, node: 67, tag: u, level: 14" node_number="67">Advanced Search</u></a> </div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 7" node_number="68"> <div class="valid" valid="valid" title="valid: True, node: 69, tag: div, level: 8" node_number="69"> <div class="valid" valid="valid" title="valid: True, node: 70, tag: div, level: 9" node_number="70"> <h6 class="valid" valid="valid" title="valid: True, node: 71, tag: h6, level: 10" node_number="71">Trending Terms:</h6> <ul class="valid" valid="valid" title="valid: True, node: 72, tag: ul, level: 10" node_number="72"> <li class="valid" valid="valid" title="valid: True, node: 73, tag: li, level: 11" node_number="73"> <a class="valid" valid="valid" title="valid: True, node: 74, tag: a, level: 12" node_number="74">covid-19</a> </li> <li class="valid" valid="valid" title="valid: True, node: 75, tag: li, level: 11" node_number="75"> <a class="valid" valid="valid" title="valid: True, node: 76, tag: a, level: 12" node_number="76">climate</a> </li> <li class="valid" valid="valid" title="valid: True, node: 77, tag: li, level: 11" node_number="77"> <a class="valid" valid="valid" title="valid: True, node: 78, tag: a, level: 12" node_number="78">science policy</a> </li> <li class="valid" valid="valid" title="valid: True, node: 79, tag: li, level: 11" node_number="79"> <a class="valid" valid="valid" title="valid: True, node: 80, tag: a, level: 12" node_number="80">genome editing</a> </li> <li class="valid" valid="valid" title="valid: True, node: 81, tag: li, level: 11" node_number="81"> <a class="valid" valid="valid" title="valid: True, node: 82, tag: a, level: 12" node_number="82">batteries</a> </li> </ul> </div> </div> </div> </div> </header><div class="valid" valid="valid" title="valid: True, node: 83, tag: div, level: 5" node_number="83"><div class="valid" valid="valid" title="valid: True, node: 84, tag: div, level: 6" node_number="84"><div class="valid" valid="valid" title="valid: True, node: 85, tag: div, level: 7" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 8" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 9" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 10" node_number="88"> <li class="valid" valid="valid" title="valid: True, node: 89, tag: li, level: 11" node_number="89"> <a class="valid" valid="valid" title="valid: True, node: 90, tag: a, level: 12" node_number="90">Current Issue</a> </li> <li class="valid" valid="valid" title="valid: True, node: 91, tag: li, level: 11" node_number="91"> <a class="valid" valid="valid" title="valid: True, node: 92, tag: a, level: 12" node_number="92">First release papers</a> </li> <li class="valid" valid="valid" title="valid: True, node: 93, tag: li, level: 11" node_number="93"> <a class="valid" valid="valid" title="valid: True, node: 94, tag: a, level: 12" node_number="94">Archive</a> </li> <li class="valid" valid="valid" title="valid: True, node: 95, tag: li, level: 11" node_number="95"> <div class="valid" valid="valid" title="valid: True, node: 96, tag: div, level: 12" node_number="96"> <a class="valid" valid="valid" title="valid: True, node: 97, tag: a, level: 13" node_number="97">About</a> <div class="valid" valid="valid" title="valid: True, node: 98, tag: div, level: 13" node_number="98"> <a class="valid" valid="valid" title="valid: True, node: 99, tag: a, level: 14" node_number="99">About Science Translational Medicine</a> <a class="valid" valid="valid" title="valid: True, node: 100, tag: a, level: 14" node_number="100">Mission Scope</a> <a class="valid" valid="valid" title="valid: True, node: 101, tag: a, level: 14" node_number="101">Editors and Advisory Boards</a> <a class="valid" valid="valid" title="valid: True, node: 102, tag: a, level: 14" node_number="102">Editorial Policies</a> <a class="valid" valid="valid" title="valid: True, node: 103, tag: a, level: 14" node_number="103">Information for Authors</a> <a class="valid" valid="valid" title="valid: True, node: 104, tag: a, level: 14" node_number="104">Information for Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 105, tag: a, level: 14" node_number="105">Journal Metrics</a> <a class="valid" valid="valid" title="valid: True, node: 106, tag: a, level: 14" node_number="106">Staff</a> <a class="valid" valid="valid" title="valid: True, node: 107, tag: a, level: 14" node_number="107">Contact Us</a> <a class="valid" valid="valid" title="valid: True, node: 108, tag: a, level: 14" node_number="108">Subscribe</a> <a class="valid" valid="valid" title="valid: True, node: 109, tag: a, level: 14" node_number="109">Free Sample Articles</a> </div> </div> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 110, tag: div, level: 9" node_number="110"> <ul class="valid" valid="valid" title="valid: True, node: 111, tag: ul, level: 10" node_number="111"> <li class="valid" valid="valid" title="valid: True, node: 112, tag: li, level: 11" node_number="112"> <a class="valid" valid="valid" title="valid: True, node: 113, tag: a, level: 12" node_number="113">Submit manuscript</a> </li> <li class="valid" valid="valid" title="valid: True, node: 114, tag: li, level: 11" node_number="114"> <div class="valid" valid="valid" title="valid: True, node: 115, tag: div, level: 12" node_number="115"> <a class="valid" valid="valid" title="valid: True, node: 116, tag: a, level: 13" node_number="116">More</a> </div> </li> </ul> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 117, tag: a, level: 8" node_number="117">GET OUR E-ALERTS</a> </div></div></div> <main class="valid" valid="valid" title="valid: True, node: 118, tag: main, level: 5" node_number="118"> <div class="valid" valid="valid" title="valid: True, node: 119, tag: div, level: 6" node_number="119"><div class="valid" valid="valid" title="valid: True, node: 120, tag: div, level: 7" node_number="120"><div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 8" node_number="121"><div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 9" node_number="122"><div class="valid" valid="valid" title="valid: True, node: 123, tag: div, level: 10" node_number="123"> <div class="valid" valid="valid" title="valid: True, node: 124, tag: div, level: 11" node_number="124"><a class="valid" valid="valid" title="valid: True, node: 125, tag: a, level: 12" node_number="125">Home</a><a class="valid" valid="valid" title="valid: True, node: 126, tag: a, level: 12" node_number="126">Science Translational Medicine</a><a class="valid" valid="valid" title="valid: True, node: 127, tag: a, level: 12" node_number="127">Vol. 13, No. 625</a>A human orthogonal IL-2 and IL-2R&#946; system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</div><div class="valid" valid="valid" title="valid: True, node: 128, tag: div, level: 11" node_number="128">Back To Vol. 13, No. 625</div> </div> <article class="valid" valid="valid" title="valid: True, node: 129, tag: article, level: 10" node_number="129"><section class="valid" valid="valid" title="valid: True, node: 130, tag: section, level: 11" node_number="130"><header class="valid" valid="valid" title="valid: True, node: 131, tag: header, level: 12" node_number="131"><div class="valid" valid="valid" title="valid: True, node: 132, tag: div, level: 13" node_number="132"><div class="valid" valid="valid" title="valid: True, node: 133, tag: div, level: 14" node_number="133"><div title="valid: False, node: 134, tag: div, level: 15" node_number="134"><div title="valid: False, node: 135, tag: div, level: 16" node_number="135">Research Article</div><div title="valid: False, node: 136, tag: div, level: 16" node_number="136">CANCER</div></div><div title="valid: False, node: 137, tag: div, level: 15" node_number="137"><div title="valid: False, node: 138, tag: div, level: 16" node_number="138"> <div title="valid: False, node: 139, tag: div, level: 17" node_number="139">Share on</div> </div></div></div><h1 class="valid" valid="valid" title="valid: True, node: 140, tag: h1, level: 14" node_number="140">A human orthogonal IL-2 and IL-2R&#946; system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</h1><div class="valid" valid="valid" title="valid: True, node: 141, tag: div, level: 14" node_number="141">Qian Zhang https://orcid.org/0000-0002-2858-0962, Morgan E. Hresko https://orcid.org/0000-0003-1322-3791, Lora K. Picton https://orcid.org/0000-0002-0482-5187, Leon Su https://orcid.org/0000-0001-7654-9997, Michael J. Hollander https://orcid.org/0000-0002-3108-2788, Selene Nunez-Cruz, Zheng Zhang https://orcid.org/0000-0002-3242-5738, Charles-Antoine Assenmacher https://orcid.org/0000-0003-0073-2730, Jonathan T. Sockolosky https://orcid.org/0000-0002-5441-1409, K. Christopher Garcia https://orcid.org/0000-0001-9273-0278 [email&#160;protected], and Michael C. Milone https://orcid.org/0000-0002-1580-9844 [email&#160;protected]</div><div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 14" node_number="142">Science Translational Medicine &#8226; 22 Dec 2021 &#8226; Vol 13, Issue 625 &#8226; DOI: 10.1126/scitranslmed.abg6986</div><div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 14" node_number="143"><div title="valid: False, node: 144, tag: div, level: 15" node_number="144"> <div title="valid: False, node: 145, tag: div, level: 16" node_number="145"> <a title="valid: False, node: 146, tag: a, level: 17" node_number="146"><div title="valid: False, node: 147, tag: div, level: 18" node_number="147"><div title="valid: False, node: 148, tag: div, level: 19" node_number="148"><h6 title="valid: False, node: 149, tag: h6, level: 20" node_number="149">PREVIOUS ARTICLE</h6><div title="valid: False, node: 150, tag: div, level: 20" node_number="150">Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics</div></div></div>Previous</a><a title="valid: False, node: 151, tag: a, level: 17" node_number="151"><div title="valid: False, node: 152, tag: div, level: 18" node_number="152"><div title="valid: False, node: 153, tag: div, level: 19" node_number="153"><h6 title="valid: False, node: 154, tag: h6, level: 20" node_number="154">NEXT ARTICLE</h6><div title="valid: False, node: 155, tag: div, level: 20" node_number="155">An orthogonal IL-2 and IL-2R&#946; system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</div></div></div>Next</a> </div> </div><div title="valid: False, node: 156, tag: div, level: 15" node_number="156"><div title="valid: False, node: 157, tag: div, level: 16" node_number="157">get access</div></div></div><section class="valid" valid="valid" title="valid: True, node: 158, tag: section, level: 14" node_number="158"><div title="valid: False, node: 159, tag: div, level: 15" node_number="159"><div title="valid: False, node: 160, tag: div, level: 16" node_number="160"><div title="valid: False, node: 161, tag: div, level: 17" node_number="161">Related Research Article</div><div title="valid: False, node: 162, tag: div, level: 17" node_number="162"><h6 title="valid: False, node: 163, tag: h6, level: 18" node_number="163">An orthogonal IL-2 and IL-2R&#946; system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h6></div></div></div></section></div></header><div class="valid" valid="valid" title="valid: True, node: 164, tag: div, level: 12" node_number="164"><div class="valid" valid="valid" title="valid: True, node: 165, tag: div, level: 13" node_number="165"><section class="valid" valid="valid" title="valid: True, node: 166, tag: section, level: 14" node_number="166"><h2 title="valid: False, node: 167, tag: h2, level: 15" node_number="167">An orthogonal approach to cancer</h2><div title="valid: False, node: 168, tag: div, level: 15" node_number="168">Interleukin-2 (IL-2) is an important cytokine for T cell activation and has been considered as a treatment for cancer. However, systemic administration of IL-2 often leads to severe toxicity. To address this, Zhang <i title="valid: False, node: 169, tag: i, level: 16" node_number="169">et al.</i> and Aspuria <i title="valid: False, node: 170, tag: i, level: 16" node_number="170">et al.</i> engineered T cells to express an IL-2 receptor &#946; (IL-2R&#946;) that can only be activated by a modified, orthogonal IL-2. Orthogonal IL-2R&#946; was introduced to CAR T cells targeting CD19, and the CAR T cells were transferred to mice bearing leukemias or lymphomas. Administration of orthogonal IL-2 to CAR T cell recipients drove activation, expansion, and antitumor efficacy of CAR T cells in both preclinical models with limited systemic toxicity. Thus, orthogonal cytokine-receptor pairs may offer a safer approach to enhance adoptive cell therapy.</div></section><section class="valid" valid="valid" title="valid: True, node: 171, tag: section, level: 14" node_number="171"><h2 title="valid: False, node: 172, tag: h2, level: 15" node_number="172">Abstract</h2><div title="valid: False, node: 173, tag: div, level: 15" node_number="173">Interleukin-2 (IL-2) is a central T cell cytokine that promotes T cell proliferation and effector function; however, toxicity due to its pluripotency limits its application to enhance CAR T cell immunotherapy. Previously, mouse IL-2 and its cognate receptor were engineered to create an orthogonal (<i title="valid: False, node: 174, tag: i, level: 16" node_number="174">ortho</i>) cytokine-cytokine receptor pair capable of delivering an IL-2 signal without toxicity. Here, we engineered a human orthogonal IL-2 (<i title="valid: False, node: 175, tag: i, level: 16" node_number="175">ortho-</i>hIL-2) and human orthogonal IL-2R&#946; (<i title="valid: False, node: 176, tag: i, level: 16" node_number="176">ortho-</i>hIL-2R&#946;) pair, containing human-specific mutations. <i title="valid: False, node: 177, tag: i, level: 16" node_number="177">Ortho-</i>hIL-2 is selective toward <i title="valid: False, node: 178, tag: i, level: 16" node_number="178">ortho-</i>hIL-2R&#946;&#8211;expressing cells with no appreciable signaling on wild-type T cells. <i title="valid: False, node: 179, tag: i, level: 16" node_number="179">Ortho-</i>hIL-2 induces IL-2 receptor signaling and supports proliferation of both an IL-2&#8211;dependent cell line and primary T cells transduced to express the <i title="valid: False, node: 180, tag: i, level: 16" node_number="180">ortho-</i>hIL-2R&#946;. Using CD19-specific chimeric antigen receptor (CAR) T cells, we show that <i title="valid: False, node: 181, tag: i, level: 16" node_number="181">ortho</i>-hIL-2 induces a dose-dependent increase in <i title="valid: False, node: 182, tag: i, level: 16" node_number="182">ortho</i>-hIL-2R&#946;<sup title="valid: False, node: 183, tag: sup, level: 16" node_number="183">+</sup> CAR T cell expansion in vivo by as much as 1000-fold at 2 weeks after adoptive transfer into immunodeficient mice bearing CD19<sup title="valid: False, node: 184, tag: sup, level: 16" node_number="184">+</sup> Nalm6 leukemia xenografts. <i title="valid: False, node: 185, tag: i, level: 16" node_number="185">Ortho</i>-hIL-2 can rescue the antileukemic effect of an otherwise suboptimal CAR T cell dose. In addition, <i title="valid: False, node: 186, tag: i, level: 16" node_number="186">ortho</i>-hIL-2 administration initiated at the time of leukemic relapse after CAR T cell therapy can rescue an otherwise failed antileukemic response. These data highlight the potential of combining an orthogonal cytokine approach with T cell&#8211;based immunotherapies to augment the antitumor efficacy of engineered T cells.</div></section></div></div></section><section class="valid" valid="valid" title="valid: True, node: 187, tag: section, level: 11" node_number="187"><div class="valid" valid="valid" title="valid: True, node: 188, tag: div, level: 12" node_number="188"><div class="valid" valid="valid" title="valid: True, node: 189, tag: div, level: 13" node_number="189"><div class="valid" valid="valid" title="valid: True, node: 190, tag: div, level: 14" node_number="190"><h5 title="valid: False, node: 191, tag: h5, level: 15" node_number="191">Get full access to this article</h5><p title="valid: False, node: 192, tag: p, level: 15" node_number="192">View all available purchase options and get full access to this article.</p><div title="valid: False, node: 193, tag: div, level: 15" node_number="193"><a title="valid: False, node: 194, tag: a, level: 16" node_number="194"> Get Access</a></div><div title="valid: False, node: 195, tag: div, level: 15" node_number="195">Already a Subscriber?Sign In</div></div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 196, tag: section, level: 11" node_number="196"><div class="valid" valid="valid" title="valid: True, node: 197, tag: div, level: 12" node_number="197"><section class="valid" valid="valid" title="valid: True, node: 198, tag: section, level: 13" node_number="198"><h2 class="valid" valid="valid" title="valid: True, node: 199, tag: h2, level: 14" node_number="199">Supplementary Materials</h2><section class="valid" valid="valid" title="valid: True, node: 200, tag: section, level: 14" node_number="200"><h3 title="valid: False, node: 201, tag: h3, level: 15" node_number="201">This PDF file includes:</h3><div title="valid: False, node: 202, tag: div, level: 15" node_number="202"><div title="valid: False, node: 203, tag: div, level: 16" node_number="203"><div title="valid: False, node: 204, tag: div, level: 17" node_number="204">Figs. S1 to S13</div><div title="valid: False, node: 205, tag: div, level: 17" node_number="205">Table S1</div></div><div title="valid: False, node: 206, tag: div, level: 16" node_number="206"><a title="valid: False, node: 207, tag: a, level: 17" node_number="207">Download (1.56 MB)</a></div></div></section><section class="valid" valid="valid" title="valid: True, node: 208, tag: section, level: 14" node_number="208"><h3 title="valid: False, node: 209, tag: h3, level: 15" node_number="209">Other Supplementary Material for this manuscript includes the following:</h3><div title="valid: False, node: 210, tag: div, level: 15" node_number="210"><div title="valid: False, node: 211, tag: div, level: 16" node_number="211"><div title="valid: False, node: 212, tag: div, level: 17" node_number="212">Data File S1</div></div><div title="valid: False, node: 213, tag: div, level: 16" node_number="213"><a title="valid: False, node: 214, tag: a, level: 17" node_number="214">Download (100.23 KB)</a></div></div></section></section><div class="valid" valid="valid" title="valid: True, node: 215, tag: div, level: 13" node_number="215"><a class="valid" valid="valid" title="valid: True, node: 216, tag: a, level: 14" node_number="216">View/request a protocol for this paper from <i title="valid: False, node: 217, tag: i, level: 15" node_number="217">Bio-protocol</i>.</a></div><section class="valid" valid="valid" title="valid: True, node: 218, tag: section, level: 13" node_number="218"><h2 class="valid" valid="valid" title="valid: True, node: 219, tag: h2, level: 14" node_number="219">REFERENCES AND NOTES</h2><div class="valid" valid="valid" title="valid: True, node: 220, tag: div, level: 14" node_number="220"><div title="valid: False, node: 221, tag: div, level: 15" node_number="221">1</div><div title="valid: False, node: 222, tag: div, level: 15" node_number="222"><div title="valid: False, node: 223, tag: div, level: 16" node_number="223"><div title="valid: False, node: 224, tag: div, level: 17" node_number="224">C. H. June, R. S. O&#8217;Connor, O. U. Kawalekar, S. Ghassemi, M. C. Milone, CAR T cell immunotherapy for human cancer. Science <b title="valid: False, node: 225, tag: b, level: 18" node_number="225">359</b>, 1361&#8211;1365 (2018).</div><div title="valid: False, node: 226, tag: div, level: 17" node_number="226"><div title="valid: False, node: 227, tag: div, level: 18" node_number="227"><a title="valid: False, node: 228, tag: a, level: 19" node_number="228">Crossref</a></div><div title="valid: False, node: 229, tag: div, level: 18" node_number="229"><a title="valid: False, node: 230, tag: a, level: 19" node_number="230">PubMed</a></div><div title="valid: False, node: 231, tag: div, level: 18" node_number="231"><a title="valid: False, node: 232, tag: a, level: 19" node_number="232">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 233, tag: div, level: 14" node_number="233"><div title="valid: False, node: 234, tag: div, level: 15" node_number="234">2</div><div title="valid: False, node: 235, tag: div, level: 15" node_number="235"><div title="valid: False, node: 236, tag: div, level: 16" node_number="236"><div title="valid: False, node: 237, tag: div, level: 17" node_number="237">J. N. Kochenderfer, M. E. Dudley, S. H. Kassim, R. P. Somerville, R. O. Carpenter, M. Stetler-Stevenson, J. C. Yang, G. Q. Phan, M. S. Hughes, R. M. Sherry, M. Raffeld, S. Feldman, L. Lu, Y. F. Li, L. T. Ngo, A. Goy, T. Feldman, D. E. Spaner, M. L. Wang, C. C. Chen, S. M. Kranick, A. Nath, D.-A. N. Nathan, K. E. Morton, M. A. Toomey, S. A. Rosenberg, Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J. Clin. Oncol. <b title="valid: False, node: 238, tag: b, level: 18" node_number="238">33</b>, 540&#8211;549 (2015).</div><div title="valid: False, node: 239, tag: div, level: 17" node_number="239"><div title="valid: False, node: 240, tag: div, level: 18" node_number="240"><a title="valid: False, node: 241, tag: a, level: 19" node_number="241">Crossref</a></div><div title="valid: False, node: 242, tag: div, level: 18" node_number="242"><a title="valid: False, node: 243, tag: a, level: 19" node_number="243">PubMed</a></div><div title="valid: False, node: 244, tag: div, level: 18" node_number="244"><a title="valid: False, node: 245, tag: a, level: 19" node_number="245">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 246, tag: div, level: 14" node_number="246"><div title="valid: False, node: 247, tag: div, level: 15" node_number="247">3</div><div title="valid: False, node: 248, tag: div, level: 15" node_number="248"><div title="valid: False, node: 249, tag: div, level: 16" node_number="249"><div title="valid: False, node: 250, tag: div, level: 17" node_number="250">S. L. Maude, T. W. Laetsch, J. Buechner, S. Rives, M. Boyer, H. Bittencourt, P. Bader, M. R. Verneris, H. E. Stefanski, G. D. Myers, M. Qayed, B. De Moerloose, H. Hiramatsu, K. Schlis, K. L. Davis, P. L. Martin, E. R. Nemecek, G. A. Yanik, C. Peters, A. Baruchel, N. Boissel, F. Mechinaud, A. Balduzzi, J. Krueger, C. H. June, B. L. Levine, P. Wood, T. Taran, M. Leung, K. T. Mueller, Y. Zhang, K. Sen, D. Lebwohl, M. A. Pulsipher, S. A. Grupp, Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. <b title="valid: False, node: 251, tag: b, level: 18" node_number="251">378</b>, 439&#8211;448 (2018).</div><div title="valid: False, node: 252, tag: div, level: 17" node_number="252"><div title="valid: False, node: 253, tag: div, level: 18" node_number="253"><a title="valid: False, node: 254, tag: a, level: 19" node_number="254">Crossref</a></div><div title="valid: False, node: 255, tag: div, level: 18" node_number="255"><a title="valid: False, node: 256, tag: a, level: 19" node_number="256">PubMed</a></div><div title="valid: False, node: 257, tag: div, level: 18" node_number="257"><a title="valid: False, node: 258, tag: a, level: 19" node_number="258">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 259, tag: div, level: 14" node_number="259"><div title="valid: False, node: 260, tag: div, level: 15" node_number="260">4</div><div title="valid: False, node: 261, tag: div, level: 15" node_number="261"><div title="valid: False, node: 262, tag: div, level: 16" node_number="262"><div title="valid: False, node: 263, tag: div, level: 17" node_number="263">D. L. Porter, W.-T. Hwang, N. V. Frey, S. F. Lacey, P. A. Shaw, A. W. Loren, A. Bagg, K. T. Marcucci, A. Shen, V. Gonzalez, D. Ambrose, S. A. Grupp, A. Chew, Z. Zheng, M. C. Milone, B. L. Levine, J. J. Melenhorst, C. H. June, Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci. Transl. Med. <b title="valid: False, node: 264, tag: b, level: 18" node_number="264">7</b>, 303ra139 (2015).</div><div title="valid: False, node: 265, tag: div, level: 17" node_number="265"><div title="valid: False, node: 266, tag: div, level: 18" node_number="266"><a title="valid: False, node: 267, tag: a, level: 19" node_number="267">Crossref</a></div><div title="valid: False, node: 268, tag: div, level: 18" node_number="268"><a title="valid: False, node: 269, tag: a, level: 19" node_number="269">PubMed</a></div><div title="valid: False, node: 270, tag: div, level: 18" node_number="270"><a title="valid: False, node: 271, tag: a, level: 19" node_number="271">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 272, tag: div, level: 14" node_number="272"><div title="valid: False, node: 273, tag: div, level: 15" node_number="273">5</div><div title="valid: False, node: 274, tag: div, level: 15" node_number="274"><div title="valid: False, node: 275, tag: div, level: 16" node_number="275"><div title="valid: False, node: 276, tag: div, level: 17" node_number="276">S. J. Schuster, M. R. Bishop, C. S. Tam, E. K. Waller, P. Borchmann, J. P. McGuirk, U. J&#228;ger, S. Jaglowski, C. Andreadis, J. R. Westin, I. Fleury, V. Bachanova, S. R. Foley, P. J. Ho, S. Mielke, J. M. Magenau, H. Holte, S. Pantano, L. B. Pacaud, R. Awasthi, J. Chu, &#214;. Anak, G. Salles, R. T. Maziarz, Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N. Engl. J. Med. <b title="valid: False, node: 277, tag: b, level: 18" node_number="277">380</b>, 45&#8211;56 (2019).</div><div title="valid: False, node: 278, tag: div, level: 17" node_number="278"><div title="valid: False, node: 279, tag: div, level: 18" node_number="279"><a title="valid: False, node: 280, tag: a, level: 19" node_number="280">Crossref</a></div><div title="valid: False, node: 281, tag: div, level: 18" node_number="281"><a title="valid: False, node: 282, tag: a, level: 19" node_number="282">PubMed</a></div><div title="valid: False, node: 283, tag: div, level: 18" node_number="283"><a title="valid: False, node: 284, tag: a, level: 19" node_number="284">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 285, tag: div, level: 14" node_number="285"><div title="valid: False, node: 286, tag: div, level: 15" node_number="286">6</div><div title="valid: False, node: 287, tag: div, level: 15" node_number="287"><div title="valid: False, node: 288, tag: div, level: 16" node_number="288"><div title="valid: False, node: 289, tag: div, level: 17" node_number="289">F. L. Locke, A. Ghobadi, C. A. Jacobson, D. B. Miklos, L. J. Lekakis, O. O. Oluwole, Y. Lin, I. Braunschweig, B. T. Hill, J. M. Timmerman, A. Deol, P. M. Reagan, P. Stiff, I. W. Flinn, U. Farooq, A. Goy, P. A. McSweeney, J. Munoz, T. Siddiqi, J. C. Chavez, A. F. Herrera, N. L. Bartlett, J. S. Wiezorek, L. Navale, A. Xue, Y. Jiang, A. Bot, J. M. Rossi, J. J. Kim, W. Y. Go, S. S. Neelapu, Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): A single-arm, multicentre, phase 1-2 trial. Lancet Oncol. <b title="valid: False, node: 290, tag: b, level: 18" node_number="290">20</b>, 31&#8211;42 (2019).</div><div title="valid: False, node: 291, tag: div, level: 17" node_number="291"><div title="valid: False, node: 292, tag: div, level: 18" node_number="292"><a title="valid: False, node: 293, tag: a, level: 19" node_number="293">Crossref</a></div><div title="valid: False, node: 294, tag: div, level: 18" node_number="294"><a title="valid: False, node: 295, tag: a, level: 19" node_number="295">PubMed</a></div><div title="valid: False, node: 296, tag: div, level: 18" node_number="296"><a title="valid: False, node: 297, tag: a, level: 19" node_number="297">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 298, tag: div, level: 14" node_number="298"><div title="valid: False, node: 299, tag: div, level: 15" node_number="299">7</div><div title="valid: False, node: 300, tag: div, level: 15" node_number="300"><div title="valid: False, node: 301, tag: div, level: 16" node_number="301"><div title="valid: False, node: 302, tag: div, level: 17" node_number="302">N. Raje, J. Berdeja, Y. Lin, D. Siegel, S. Jagannath, D. Madduri, M. Liedtke, J. Rosenblatt, M. V. Maus, A. Turka, L.-P. Lam, R. A. Morgan, K. Friedman, M. Massaro, J. Wang, G. Russotti, Z. Yang, T. Campbell, K. Hege, F. Petrocca, M. T. Quigley, N. Munshi, J. N. Kochenderfer, Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma. N. Engl. J. Med. <b title="valid: False, node: 303, tag: b, level: 18" node_number="303">380</b>, 1726&#8211;1737 (2019).</div><div title="valid: False, node: 304, tag: div, level: 17" node_number="304"><div title="valid: False, node: 305, tag: div, level: 18" node_number="305"><a title="valid: False, node: 306, tag: a, level: 19" node_number="306">Crossref</a></div><div title="valid: False, node: 307, tag: div, level: 18" node_number="307"><a title="valid: False, node: 308, tag: a, level: 19" node_number="308">PubMed</a></div><div title="valid: False, node: 309, tag: div, level: 18" node_number="309"><a title="valid: False, node: 310, tag: a, level: 19" node_number="310">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 311, tag: div, level: 14" node_number="311"><div title="valid: False, node: 312, tag: div, level: 15" node_number="312">8</div><div title="valid: False, node: 313, tag: div, level: 15" node_number="313"><div title="valid: False, node: 314, tag: div, level: 16" node_number="314"><div title="valid: False, node: 315, tag: div, level: 17" node_number="315">A. D. Cohen, A. L. Garfall, E. A. Stadtmauer, J. J. Melenhorst, S. F. Lacey, E. Lancaster, D. T. Vogl, B. M. Weiss, K. Dengel, A. Nelson, G. Plesa, F. Chen, M. M. Davis, W.-T. Hwang, R. M. Young, J. L. Brogdon, R. Isaacs, I. Pruteanu-Malinici, D. L. Siegel, B. L. Levine, C. H. June, M. C. Milone, B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma. J. Clin. Invest. <b title="valid: False, node: 316, tag: b, level: 18" node_number="316">129</b>, 2210&#8211;2221 (2019).</div><div title="valid: False, node: 317, tag: div, level: 17" node_number="317"><div title="valid: False, node: 318, tag: div, level: 18" node_number="318"><a title="valid: False, node: 319, tag: a, level: 19" node_number="319">Crossref</a></div><div title="valid: False, node: 320, tag: div, level: 18" node_number="320"><a title="valid: False, node: 321, tag: a, level: 19" node_number="321">PubMed</a></div><div title="valid: False, node: 322, tag: div, level: 18" node_number="322"><a title="valid: False, node: 323, tag: a, level: 19" node_number="323">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 324, tag: div, level: 14" node_number="324"><div title="valid: False, node: 325, tag: div, level: 15" node_number="325">9</div><div title="valid: False, node: 326, tag: div, level: 15" node_number="326"><div title="valid: False, node: 327, tag: div, level: 16" node_number="327"><div title="valid: False, node: 328, tag: div, level: 17" node_number="328">J. A. Fraietta, S. F. Lacey, E. J. Orlando, I. Pruteanu-Malinici, M. Gohil, S. Lundh, A. C. Boesteanu, Y. Wang, R. S. O&#8217;Connor, W.-T. Hwang, E. Pequignot, D. E. Ambrose, C. Zhang, N. Wilcox, F. Bedoya, C. Dorfmeier, F. Chen, L. Tian, H. Parakandi, M. Gupta, R. M. Young, F. B. Johnson, I. Kulikovskaya, L. Liu, J. Xu, S. H. Kassim, M. M. Davis, B. L. Levine, N. V. Frey, D. L. Siegel, A. C. Huang, E. J. Wherry, H. Bitter, J. L. Brogdon, D. L. Porter, C. H. June, J. J. Melenhorst, Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat. Med. <b title="valid: False, node: 329, tag: b, level: 18" node_number="329">24</b>, 563&#8211;571 (2018).</div><div title="valid: False, node: 330, tag: div, level: 17" node_number="330"><div title="valid: False, node: 331, tag: div, level: 18" node_number="331"><a title="valid: False, node: 332, tag: a, level: 19" node_number="332">Crossref</a></div><div title="valid: False, node: 333, tag: div, level: 18" node_number="333"><a title="valid: False, node: 334, tag: a, level: 19" node_number="334">PubMed</a></div><div title="valid: False, node: 335, tag: div, level: 18" node_number="335"><a title="valid: False, node: 336, tag: a, level: 19" node_number="336">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 337, tag: div, level: 14" node_number="337"><div title="valid: False, node: 338, tag: div, level: 15" node_number="338">10</div><div title="valid: False, node: 339, tag: div, level: 15" node_number="339"><div title="valid: False, node: 340, tag: div, level: 16" node_number="340"><div title="valid: False, node: 341, tag: div, level: 17" node_number="341">E. Sotillo, D. M. Barrett, K. L. Black, A. Bagashev, D. Oldridge, G. Wu, R. Sussman, C. Lanauze, M. Ruella, M. R. Gazzara, N. M. Martinez, C. T. Harrington, E. Y. Chung, J. Perazzelli, T. J. Hofmann, S. L. Maude, P. Raman, A. Barrera, S. Gill, S. F. Lacey, J. J. Melenhorst, D. Allman, E. Jacoby, T. Fry, C. Mackall, Y. Barash, K. W. Lynch, J. M. Maris, S. A. Grupp, A. Thomas-Tikhonenko, Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy. Cancer Discov. <b title="valid: False, node: 342, tag: b, level: 18" node_number="342">5</b>, 1282&#8211;1295 (2015).</div><div title="valid: False, node: 343, tag: div, level: 17" node_number="343"><div title="valid: False, node: 344, tag: div, level: 18" node_number="344"><a title="valid: False, node: 345, tag: a, level: 19" node_number="345">Crossref</a></div><div title="valid: False, node: 346, tag: div, level: 18" node_number="346"><a title="valid: False, node: 347, tag: a, level: 19" node_number="347">PubMed</a></div><div title="valid: False, node: 348, tag: div, level: 18" node_number="348"><a title="valid: False, node: 349, tag: a, level: 19" node_number="349">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 350, tag: div, level: 14" node_number="350"><div title="valid: False, node: 351, tag: div, level: 15" node_number="351">11</div><div title="valid: False, node: 352, tag: div, level: 15" node_number="352"><div title="valid: False, node: 353, tag: div, level: 16" node_number="353"><div title="valid: False, node: 354, tag: div, level: 17" node_number="354">S. A. Rosenberg, IL-2: The first effective immunotherapy for human cancer. J. Immunol. <b title="valid: False, node: 355, tag: b, level: 18" node_number="355">192</b>, 5451&#8211;5458 (2014).</div><div title="valid: False, node: 356, tag: div, level: 17" node_number="356"><div title="valid: False, node: 357, tag: div, level: 18" node_number="357"><a title="valid: False, node: 358, tag: a, level: 19" node_number="358">Crossref</a></div><div title="valid: False, node: 359, tag: div, level: 18" node_number="359"><a title="valid: False, node: 360, tag: a, level: 19" node_number="360">PubMed</a></div><div title="valid: False, node: 361, tag: div, level: 18" node_number="361"><a title="valid: False, node: 362, tag: a, level: 19" node_number="362">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 363, tag: div, level: 14" node_number="363"><div title="valid: False, node: 364, tag: div, level: 15" node_number="364">12</div><div title="valid: False, node: 365, tag: div, level: 15" node_number="365"><div title="valid: False, node: 366, tag: div, level: 16" node_number="366"><div title="valid: False, node: 367, tag: div, level: 17" node_number="367">L. A. Matis, S. Shu, E. S. Groves, S. Zinn, T. Chou, A. M. Kruisbeek, M. Rosenstein, S. A. Rosenberg, Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: Correlation with clonal IL 2 receptor expression. J. Immunol. <b title="valid: False, node: 368, tag: b, level: 18" node_number="368">136</b>, 3496&#8211;3501 (1986).</div><div title="valid: False, node: 369, tag: div, level: 17" node_number="369"><div title="valid: False, node: 370, tag: div, level: 18" node_number="370"><a title="valid: False, node: 371, tag: a, level: 19" node_number="371">PubMed</a></div><div title="valid: False, node: 372, tag: div, level: 18" node_number="372"><a title="valid: False, node: 373, tag: a, level: 19" node_number="373">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 374, tag: div, level: 14" node_number="374"><div title="valid: False, node: 375, tag: div, level: 15" node_number="375">13</div><div title="valid: False, node: 376, tag: div, level: 15" node_number="376"><div title="valid: False, node: 377, tag: div, level: 16" node_number="377"><div title="valid: False, node: 378, tag: div, level: 17" node_number="378">M. J. Besser, R. Shapira-Frommer, O. Itzhaki, A. J. Treves, D. B. Zippel, D. Levy, A. Kubi, N. Shoshani, D. Zikich, Y. Ohayon, D. Ohayon, B. Shalmon, G. Markel, R. Yerushalmi, S. Apter, A. Ben-Nun, E. Ben-Ami, A. Shimoni, A. Nagler, J. Schachter, Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: Intent-to-treat analysis and efficacy after failure to prior immunotherapies. Clin. Cancer Res. <b title="valid: False, node: 379, tag: b, level: 18" node_number="379">19</b>, 4792&#8211;4800 (2013).</div><div title="valid: False, node: 380, tag: div, level: 17" node_number="380"><div title="valid: False, node: 381, tag: div, level: 18" node_number="381"><a title="valid: False, node: 382, tag: a, level: 19" node_number="382">Crossref</a></div><div title="valid: False, node: 383, tag: div, level: 18" node_number="383"><a title="valid: False, node: 384, tag: a, level: 19" node_number="384">PubMed</a></div><div title="valid: False, node: 385, tag: div, level: 18" node_number="385"><a title="valid: False, node: 386, tag: a, level: 19" node_number="386">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 387, tag: div, level: 14" node_number="387"><div title="valid: False, node: 388, tag: div, level: 15" node_number="388">14</div><div title="valid: False, node: 389, tag: div, level: 15" node_number="389"><div title="valid: False, node: 390, tag: div, level: 16" node_number="390"><div title="valid: False, node: 391, tag: div, level: 17" node_number="391">J. P. Dutcher, Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma. Oncology <b title="valid: False, node: 392, tag: b, level: 18" node_number="392">16</b>, 4&#8211;10 (2002).</div><div title="valid: False, node: 393, tag: div, level: 17" node_number="393"><div title="valid: False, node: 394, tag: div, level: 18" node_number="394"><a title="valid: False, node: 395, tag: a, level: 19" node_number="395">PubMed</a></div><div title="valid: False, node: 396, tag: div, level: 18" node_number="396"><a title="valid: False, node: 397, tag: a, level: 19" node_number="397">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 398, tag: div, level: 14" node_number="398"><div title="valid: False, node: 399, tag: div, level: 15" node_number="399">15</div><div title="valid: False, node: 400, tag: div, level: 15" node_number="400"><div title="valid: False, node: 401, tag: div, level: 16" node_number="401"><div title="valid: False, node: 402, tag: div, level: 17" node_number="402">P. Dhupkar, N. Gordon, Interleukin-2: Old and new approaches to enhance immune-therapeutic efficacy. Adv. Exp. Med. Biol. <b title="valid: False, node: 403, tag: b, level: 18" node_number="403">995</b>, 33&#8211;51 (2017).</div><div title="valid: False, node: 404, tag: div, level: 17" node_number="404"><div title="valid: False, node: 405, tag: div, level: 18" node_number="405"><a title="valid: False, node: 406, tag: a, level: 19" node_number="406">Crossref</a></div><div title="valid: False, node: 407, tag: div, level: 18" node_number="407"><a title="valid: False, node: 408, tag: a, level: 19" node_number="408">PubMed</a></div><div title="valid: False, node: 409, tag: div, level: 18" node_number="409"><a title="valid: False, node: 410, tag: a, level: 19" node_number="410">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 411, tag: div, level: 14" node_number="411"><div title="valid: False, node: 412, tag: div, level: 15" node_number="412">16</div><div title="valid: False, node: 413, tag: div, level: 15" node_number="413"><div title="valid: False, node: 414, tag: div, level: 16" node_number="414"><div title="valid: False, node: 415, tag: div, level: 17" node_number="415">M. B. Atkins, J. Sparano, R. I. Fisher, G. R. Weiss, K. A. Margolin, K. I. Fink, L. Rubinstein, A. Louie, J. W. Mier, R. Gucalp, Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma. J. Clin. Oncol. <b title="valid: False, node: 416, tag: b, level: 18" node_number="416">11</b>, 661&#8211;670 (1993).</div><div title="valid: False, node: 417, tag: div, level: 17" node_number="417"><div title="valid: False, node: 418, tag: div, level: 18" node_number="418"><a title="valid: False, node: 419, tag: a, level: 19" node_number="419">Crossref</a></div><div title="valid: False, node: 420, tag: div, level: 18" node_number="420"><a title="valid: False, node: 421, tag: a, level: 19" node_number="421">PubMed</a></div><div title="valid: False, node: 422, tag: div, level: 18" node_number="422"><a title="valid: False, node: 423, tag: a, level: 19" node_number="423">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 424, tag: div, level: 14" node_number="424"><div title="valid: False, node: 425, tag: div, level: 15" node_number="425">17</div><div title="valid: False, node: 426, tag: div, level: 15" node_number="426"><div title="valid: False, node: 427, tag: div, level: 16" node_number="427"><div title="valid: False, node: 428, tag: div, level: 17" node_number="428">M. B. Atkins, M. T. Lotze, J. P. Dutcher, R. I. Fisher, G. Weiss, K. Margolin, J. Abrams, M. Sznol, D. Parkinson, M. Hawkins, C. Paradise, L. Kunkel, S. A. Rosenberg, High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993. J. Clin. Oncol. <b title="valid: False, node: 429, tag: b, level: 18" node_number="429">17</b>, 2105&#8211;2116 (1999).</div><div title="valid: False, node: 430, tag: div, level: 17" node_number="430"><div title="valid: False, node: 431, tag: div, level: 18" node_number="431"><a title="valid: False, node: 432, tag: a, level: 19" node_number="432">Crossref</a></div><div title="valid: False, node: 433, tag: div, level: 18" node_number="433"><a title="valid: False, node: 434, tag: a, level: 19" node_number="434">PubMed</a></div><div title="valid: False, node: 435, tag: div, level: 18" node_number="435"><a title="valid: False, node: 436, tag: a, level: 19" node_number="436">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 437, tag: div, level: 14" node_number="437"><div title="valid: False, node: 438, tag: div, level: 15" node_number="438">18</div><div title="valid: False, node: 439, tag: div, level: 15" node_number="439"><div title="valid: False, node: 440, tag: div, level: 16" node_number="440"><div title="valid: False, node: 441, tag: div, level: 17" node_number="441">G. Fyfe, R. I. Fisher, S. A. Rosenberg, M. Sznol, D. R. Parkinson, A. C. Louie, Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J. Clin. Oncol. <b title="valid: False, node: 442, tag: b, level: 18" node_number="442">13</b>, 688&#8211;696 (1995).</div><div title="valid: False, node: 443, tag: div, level: 17" node_number="443"><div title="valid: False, node: 444, tag: div, level: 18" node_number="444"><a title="valid: False, node: 445, tag: a, level: 19" node_number="445">Crossref</a></div><div title="valid: False, node: 446, tag: div, level: 18" node_number="446"><a title="valid: False, node: 447, tag: a, level: 19" node_number="447">PubMed</a></div><div title="valid: False, node: 448, tag: div, level: 18" node_number="448"><a title="valid: False, node: 449, tag: a, level: 19" node_number="449">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 450, tag: div, level: 14" node_number="450"><div title="valid: False, node: 451, tag: div, level: 15" node_number="451">19</div><div title="valid: False, node: 452, tag: div, level: 15" node_number="452"><div title="valid: False, node: 453, tag: div, level: 16" node_number="453"><div title="valid: False, node: 454, tag: div, level: 17" node_number="454">U. S. Kammula, D. E. White, S. A. Rosenberg, Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer. Cancer <b title="valid: False, node: 455, tag: b, level: 18" node_number="455">83</b>, 797&#8211;805 (1998).</div><div title="valid: False, node: 456, tag: div, level: 17" node_number="456"><div title="valid: False, node: 457, tag: div, level: 18" node_number="457"><a title="valid: False, node: 458, tag: a, level: 19" node_number="458">Crossref</a></div><div title="valid: False, node: 459, tag: div, level: 18" node_number="459"><a title="valid: False, node: 460, tag: a, level: 19" node_number="460">PubMed</a></div><div title="valid: False, node: 461, tag: div, level: 18" node_number="461"><a title="valid: False, node: 462, tag: a, level: 19" node_number="462">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 463, tag: div, level: 14" node_number="463"><div title="valid: False, node: 464, tag: div, level: 15" node_number="464">20</div><div title="valid: False, node: 465, tag: div, level: 15" node_number="465"><div title="valid: False, node: 466, tag: div, level: 16" node_number="466"><div title="valid: False, node: 467, tag: div, level: 17" node_number="467">J. T. Sockolosky, E. Trotta, G. Parisi, L. Picton, L. L. Su, A. C. Le, A. Chhabra, S. L. Silveria, B. M. George, I. C. King, M. R. Tiffany, K. Jude, L. V. Sibener, D. Baker, J. A. Shizuru, A. Ribas, J. A. Bluestone, K. Christopher Garcia, Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science <b title="valid: False, node: 468, tag: b, level: 18" node_number="468">359</b>, 1037&#8211;1042 (2018).</div><div title="valid: False, node: 469, tag: div, level: 17" node_number="469"><div title="valid: False, node: 470, tag: div, level: 18" node_number="470"><a title="valid: False, node: 471, tag: a, level: 19" node_number="471">Crossref</a></div><div title="valid: False, node: 472, tag: div, level: 18" node_number="472"><a title="valid: False, node: 473, tag: a, level: 19" node_number="473">PubMed</a></div><div title="valid: False, node: 474, tag: div, level: 18" node_number="474"><a title="valid: False, node: 475, tag: a, level: 19" node_number="475">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 476, tag: div, level: 14" node_number="476"><div title="valid: False, node: 477, tag: div, level: 15" node_number="477">21</div><div title="valid: False, node: 478, tag: div, level: 15" node_number="478"><div title="valid: False, node: 479, tag: div, level: 16" node_number="479"><div title="valid: False, node: 480, tag: div, level: 17" node_number="480">K. Kaltoft, S. Bisballe, H. F. Rasmussen, K. Thestrup-Pedersen, K. Thomsen, W. Sterry, A continuous T-cell line from a patient with S&#233;zary syndrome. Arch. Dermatol. Res. <b title="valid: False, node: 481, tag: b, level: 18" node_number="481">279</b>, 293&#8211;298 (1987).</div><div title="valid: False, node: 482, tag: div, level: 17" node_number="482"><div title="valid: False, node: 483, tag: div, level: 18" node_number="483"><a title="valid: False, node: 484, tag: a, level: 19" node_number="484">Crossref</a></div><div title="valid: False, node: 485, tag: div, level: 18" node_number="485"><a title="valid: False, node: 486, tag: a, level: 19" node_number="486">PubMed</a></div><div title="valid: False, node: 487, tag: div, level: 18" node_number="487"><a title="valid: False, node: 488, tag: a, level: 19" node_number="488">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 489, tag: div, level: 14" node_number="489"><div title="valid: False, node: 490, tag: div, level: 15" node_number="490">22</div><div title="valid: False, node: 491, tag: div, level: 15" node_number="491"><div title="valid: False, node: 492, tag: div, level: 16" node_number="492"><div title="valid: False, node: 493, tag: div, level: 17" node_number="493">N. Arenas-Ramirez, J. Woytschak, O. Boyman, Interleukin-2: Biology, design and application. Trends Immunol. <b title="valid: False, node: 494, tag: b, level: 18" node_number="494">36</b>, 763&#8211;777 (2015).</div><div title="valid: False, node: 495, tag: div, level: 17" node_number="495"><div title="valid: False, node: 496, tag: div, level: 18" node_number="496"><a title="valid: False, node: 497, tag: a, level: 19" node_number="497">Crossref</a></div><div title="valid: False, node: 498, tag: div, level: 18" node_number="498"><a title="valid: False, node: 499, tag: a, level: 19" node_number="499">PubMed</a></div><div title="valid: False, node: 500, tag: div, level: 18" node_number="500"><a title="valid: False, node: 501, tag: a, level: 19" node_number="501">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 502, tag: div, level: 14" node_number="502"><div title="valid: False, node: 503, tag: div, level: 15" node_number="503">23</div><div title="valid: False, node: 504, tag: div, level: 15" node_number="504"><div title="valid: False, node: 505, tag: div, level: 16" node_number="505"><div title="valid: False, node: 506, tag: div, level: 17" node_number="506">J. Eyquem, J. Mansilla-Soto, T. Giavridis, S. J. van der Stegen, M. Hamieh, K. M. Cunanan, A. Odak, M. G&#246;nen, M. Sadelain, Targeting a CAR to the <i title="valid: False, node: 507, tag: i, level: 18" node_number="507">TRAC</i> locus with CRISPR/Cas9 enhances tumour rejection. Nature <b title="valid: False, node: 508, tag: b, level: 18" node_number="508">543</b>, 113&#8211;117 (2017).</div><div title="valid: False, node: 509, tag: div, level: 17" node_number="509"><div title="valid: False, node: 510, tag: div, level: 18" node_number="510"><a title="valid: False, node: 511, tag: a, level: 19" node_number="511">Crossref</a></div><div title="valid: False, node: 512, tag: div, level: 18" node_number="512"><a title="valid: False, node: 513, tag: a, level: 19" node_number="513">PubMed</a></div><div title="valid: False, node: 514, tag: div, level: 18" node_number="514"><a title="valid: False, node: 515, tag: a, level: 19" node_number="515">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 516, tag: div, level: 14" node_number="516"><div title="valid: False, node: 517, tag: div, level: 15" node_number="517">24</div><div title="valid: False, node: 518, tag: div, level: 15" node_number="518"><div title="valid: False, node: 519, tag: div, level: 16" node_number="519"><div title="valid: False, node: 520, tag: div, level: 17" node_number="520">E. Wang, L. C. Wang, C. Y. Tsai, V. Bhoj, Z. Gershenson, E. Moon, K. Newick, J. Sun, A. Lo, T. Baradet, M. D. Feldman, D. Barrett, E. Pur&#233;, S. Albelda, M. C. Milone, Generation of potent T-cell immunotherapy for cancer using DAP12-based, multichain, chimeric immunoreceptors. Cancer Immunol. Res. <b title="valid: False, node: 521, tag: b, level: 18" node_number="521">3</b>, 815&#8211;826 (2015).</div><div title="valid: False, node: 522, tag: div, level: 17" node_number="522"><div title="valid: False, node: 523, tag: div, level: 18" node_number="523"><a title="valid: False, node: 524, tag: a, level: 19" node_number="524">Crossref</a></div><div title="valid: False, node: 525, tag: div, level: 18" node_number="525"><a title="valid: False, node: 526, tag: a, level: 19" node_number="526">PubMed</a></div><div title="valid: False, node: 527, tag: div, level: 18" node_number="527"><a title="valid: False, node: 528, tag: a, level: 19" node_number="528">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 529, tag: div, level: 14" node_number="529"><div title="valid: False, node: 530, tag: div, level: 15" node_number="530">25</div><div title="valid: False, node: 531, tag: div, level: 15" node_number="531"><div title="valid: False, node: 532, tag: div, level: 16" node_number="532"><div title="valid: False, node: 533, tag: div, level: 17" node_number="533">D. M. Barrett, Y. Zhao, X. Liu, S. Jiang, C. Carpenito, M. Kalos, R. G. Carroll, C. H. June, S. A. Grupp, Treatment of advanced leukemia in mice with mRNA engineered T cells. Hum. Gene Ther. <b title="valid: False, node: 534, tag: b, level: 18" node_number="534">22</b>, 1575&#8211;1586 (2011).</div><div title="valid: False, node: 535, tag: div, level: 17" node_number="535"><div title="valid: False, node: 536, tag: div, level: 18" node_number="536"><a title="valid: False, node: 537, tag: a, level: 19" node_number="537">Crossref</a></div><div title="valid: False, node: 538, tag: div, level: 18" node_number="538"><a title="valid: False, node: 539, tag: a, level: 19" node_number="539">PubMed</a></div><div title="valid: False, node: 540, tag: div, level: 18" node_number="540"><a title="valid: False, node: 541, tag: a, level: 19" node_number="541">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 542, tag: div, level: 14" node_number="542"><div title="valid: False, node: 543, tag: div, level: 15" node_number="543">26</div><div title="valid: False, node: 544, tag: div, level: 15" node_number="544"><div title="valid: False, node: 545, tag: div, level: 16" node_number="545"><div title="valid: False, node: 546, tag: div, level: 17" node_number="546">J. G. Pol, P. Caudana, J. Paillet, E. Piaggio, G. Kroemer, Effects of interleukin-2 in immunostimulation and immunosuppression. J. Exp. Med. <b title="valid: False, node: 547, tag: b, level: 18" node_number="547">217</b>, e20191247 (2020).</div><div title="valid: False, node: 548, tag: div, level: 17" node_number="548"><div title="valid: False, node: 549, tag: div, level: 18" node_number="549"><a title="valid: False, node: 550, tag: a, level: 19" node_number="550">Crossref</a></div><div title="valid: False, node: 551, tag: div, level: 18" node_number="551"><a title="valid: False, node: 552, tag: a, level: 19" node_number="552">PubMed</a></div><div title="valid: False, node: 553, tag: div, level: 18" node_number="553"><a title="valid: False, node: 554, tag: a, level: 19" node_number="554">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 555, tag: div, level: 14" node_number="555"><div title="valid: False, node: 556, tag: div, level: 15" node_number="556">27</div><div title="valid: False, node: 557, tag: div, level: 15" node_number="557"><div title="valid: False, node: 558, tag: div, level: 16" node_number="558"><div title="valid: False, node: 559, tag: div, level: 17" node_number="559">A. V. Hirayama, J. Gauthier, K. A. Hay, J. M. Voutsinas, Q. Wu, T. Gooley, D. Li, S. Cherian, X. Chen, B. S. Pender, R. M. Hawkins, A. Vakil, R. N. Steinmetz, U. H. Acharya, R. D. Cassaday, A. G. Chapuis, T. M. Dhawale, P. C. Hendrie, H. P. Kiem, R. C. Lynch, J. Ramos, M. Shadman, B. G. Till, S. R. Riddell, D. G. Maloney, C. J. Turtle, The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. Blood <b title="valid: False, node: 560, tag: b, level: 18" node_number="560">133</b>, 1876&#8211;1887 (2019).</div><div title="valid: False, node: 561, tag: div, level: 17" node_number="561"><div title="valid: False, node: 562, tag: div, level: 18" node_number="562"><a title="valid: False, node: 563, tag: a, level: 19" node_number="563">Crossref</a></div><div title="valid: False, node: 564, tag: div, level: 18" node_number="564"><a title="valid: False, node: 565, tag: a, level: 19" node_number="565">PubMed</a></div><div title="valid: False, node: 566, tag: div, level: 18" node_number="566"><a title="valid: False, node: 567, tag: a, level: 19" node_number="567">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 568, tag: div, level: 14" node_number="568"><div title="valid: False, node: 569, tag: div, level: 15" node_number="569">28</div><div title="valid: False, node: 570, tag: div, level: 15" node_number="570"><div title="valid: False, node: 571, tag: div, level: 16" node_number="571"><div title="valid: False, node: 572, tag: div, level: 17" node_number="572">C. A. Klebanoff, L. Gattinoni, D. C. Palmer, P. Muranski, Y. Ji, C. S. Hinrichs, Z. A. Borman, S. P. Kerkar, C. D. Scott, S. E. Finkelstein, S. A. Rosenberg, N. P. Restifo, Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice. Clin. Cancer Res. <b title="valid: False, node: 573, tag: b, level: 18" node_number="573">17</b>, 5343&#8211;5352 (2011).</div><div title="valid: False, node: 574, tag: div, level: 17" node_number="574"><div title="valid: False, node: 575, tag: div, level: 18" node_number="575"><a title="valid: False, node: 576, tag: a, level: 19" node_number="576">Crossref</a></div><div title="valid: False, node: 577, tag: div, level: 18" node_number="577"><a title="valid: False, node: 578, tag: a, level: 19" node_number="578">PubMed</a></div><div title="valid: False, node: 579, tag: div, level: 18" node_number="579"><a title="valid: False, node: 580, tag: a, level: 19" node_number="580">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 581, tag: div, level: 14" node_number="581"><div title="valid: False, node: 582, tag: div, level: 15" node_number="582">29</div><div title="valid: False, node: 583, tag: div, level: 15" node_number="583"><div title="valid: False, node: 584, tag: div, level: 16" node_number="584"><div title="valid: False, node: 585, tag: div, level: 17" node_number="585">C. A. Klebanoff, H. T. Khong, P. A. Antony, D. C. Palmer, N. P. Restifo, Sinks, suppressors and antigen presenters: How lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol. <b title="valid: False, node: 586, tag: b, level: 18" node_number="586">26</b>, 111&#8211;117 (2005).</div><div title="valid: False, node: 587, tag: div, level: 17" node_number="587"><div title="valid: False, node: 588, tag: div, level: 18" node_number="588"><a title="valid: False, node: 589, tag: a, level: 19" node_number="589">Crossref</a></div><div title="valid: False, node: 590, tag: div, level: 18" node_number="590"><a title="valid: False, node: 591, tag: a, level: 19" node_number="591">PubMed</a></div><div title="valid: False, node: 592, tag: div, level: 18" node_number="592"><a title="valid: False, node: 593, tag: a, level: 19" node_number="593">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 594, tag: div, level: 14" node_number="594"><div title="valid: False, node: 595, tag: div, level: 15" node_number="595">30</div><div title="valid: False, node: 596, tag: div, level: 15" node_number="596"><div title="valid: False, node: 597, tag: div, level: 16" node_number="597"><div title="valid: False, node: 598, tag: div, level: 17" node_number="598">P. Muranski, A. Boni, C. Wrzesinski, D. E. Citrin, S. A. Rosenberg, R. Childs, N. P. Restifo, Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go? Nat. Clin. Pract. Oncol. <b title="valid: False, node: 599, tag: b, level: 18" node_number="599">3</b>, 668&#8211;681 (2006).</div><div title="valid: False, node: 600, tag: div, level: 17" node_number="600"><div title="valid: False, node: 601, tag: div, level: 18" node_number="601"><a title="valid: False, node: 602, tag: a, level: 19" node_number="602">Crossref</a></div><div title="valid: False, node: 603, tag: div, level: 18" node_number="603"><a title="valid: False, node: 604, tag: a, level: 19" node_number="604">PubMed</a></div><div title="valid: False, node: 605, tag: div, level: 18" node_number="605"><a title="valid: False, node: 606, tag: a, level: 19" node_number="606">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 607, tag: div, level: 14" node_number="607"><div title="valid: False, node: 608, tag: div, level: 15" node_number="608">31</div><div title="valid: False, node: 609, tag: div, level: 15" node_number="609"><div title="valid: False, node: 610, tag: div, level: 16" node_number="610"><div title="valid: False, node: 611, tag: div, level: 17" node_number="611">G. C. Sim, L. Radvanyi, The IL-2 cytokine family in cancer immunotherapy. Cytokine Growth Factor Rev. <b title="valid: False, node: 612, tag: b, level: 18" node_number="612">25</b>, 377&#8211;390 (2014).</div><div title="valid: False, node: 613, tag: div, level: 17" node_number="613"><div title="valid: False, node: 614, tag: div, level: 18" node_number="614"><a title="valid: False, node: 615, tag: a, level: 19" node_number="615">Crossref</a></div><div title="valid: False, node: 616, tag: div, level: 18" node_number="616"><a title="valid: False, node: 617, tag: a, level: 19" node_number="617">PubMed</a></div><div title="valid: False, node: 618, tag: div, level: 18" node_number="618"><a title="valid: False, node: 619, tag: a, level: 19" node_number="619">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 620, tag: div, level: 14" node_number="620"><div title="valid: False, node: 621, tag: div, level: 15" node_number="621">32</div><div title="valid: False, node: 622, tag: div, level: 15" node_number="622"><div title="valid: False, node: 623, tag: div, level: 16" node_number="623"><div title="valid: False, node: 624, tag: div, level: 17" node_number="624">C. Pearson, A. Silva, M. Saini, B. Seddon, IL-7 determines the homeostatic fitness of T cells by distinct mechanisms at different signalling thresholds in vivo. Eur. J. Immunol. <b title="valid: False, node: 625, tag: b, level: 18" node_number="625">41</b>, 3656&#8211;3666 (2011).</div><div title="valid: False, node: 626, tag: div, level: 17" node_number="626"><div title="valid: False, node: 627, tag: div, level: 18" node_number="627"><a title="valid: False, node: 628, tag: a, level: 19" node_number="628">Crossref</a></div><div title="valid: False, node: 629, tag: div, level: 18" node_number="629"><a title="valid: False, node: 630, tag: a, level: 19" node_number="630">PubMed</a></div><div title="valid: False, node: 631, tag: div, level: 18" node_number="631"><a title="valid: False, node: 632, tag: a, level: 19" node_number="632">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 633, tag: div, level: 14" node_number="633"><div title="valid: False, node: 634, tag: div, level: 15" node_number="634">33</div><div title="valid: False, node: 635, tag: div, level: 15" node_number="635"><div title="valid: False, node: 636, tag: div, level: 16" node_number="636"><div title="valid: False, node: 637, tag: div, level: 17" node_number="637">F. Melchionda, T. J. Fry, M. J. Milliron, M. A. McKirdy, Y. Tagaya, C. L. Mackall, Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J. Clin. Invest. <b title="valid: False, node: 638, tag: b, level: 18" node_number="638">115</b>, 1177&#8211;1187 (2005).</div><div title="valid: False, node: 639, tag: div, level: 17" node_number="639"><div title="valid: False, node: 640, tag: div, level: 18" node_number="640"><a title="valid: False, node: 641, tag: a, level: 19" node_number="641">Crossref</a></div><div title="valid: False, node: 642, tag: div, level: 18" node_number="642"><a title="valid: False, node: 643, tag: a, level: 19" node_number="643">PubMed</a></div><div title="valid: False, node: 644, tag: div, level: 18" node_number="644"><a title="valid: False, node: 645, tag: a, level: 19" node_number="645">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 646, tag: div, level: 14" node_number="646"><div title="valid: False, node: 647, tag: div, level: 15" node_number="647">34</div><div title="valid: False, node: 648, tag: div, level: 15" node_number="648"><div title="valid: False, node: 649, tag: div, level: 16" node_number="649"><div title="valid: False, node: 650, tag: div, level: 17" node_number="650">N. L. Alves, B. Hooibrink, F. A. Arosa, R. A. W. van Lier, IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood <b title="valid: False, node: 651, tag: b, level: 18" node_number="651">102</b>, 2541&#8211;2546 (2003).</div><div title="valid: False, node: 652, tag: div, level: 17" node_number="652"><div title="valid: False, node: 653, tag: div, level: 18" node_number="653"><a title="valid: False, node: 654, tag: a, level: 19" node_number="654">Crossref</a></div><div title="valid: False, node: 655, tag: div, level: 18" node_number="655"><a title="valid: False, node: 656, tag: a, level: 19" node_number="656">PubMed</a></div><div title="valid: False, node: 657, tag: div, level: 18" node_number="657"><a title="valid: False, node: 658, tag: a, level: 19" node_number="658">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 659, tag: div, level: 14" node_number="659"><div title="valid: False, node: 660, tag: div, level: 15" node_number="660">35</div><div title="valid: False, node: 661, tag: div, level: 15" node_number="661"><div title="valid: False, node: 662, tag: div, level: 16" node_number="662"><div title="valid: False, node: 663, tag: div, level: 17" node_number="663">N. Frey, D. Porter, Cytokine release syndrome with chimeric antigen receptor T cell therapy. Biol. Blood Marrow Transplant. <b title="valid: False, node: 664, tag: b, level: 18" node_number="664">25</b>, e123&#8211;e127 (2019).</div><div title="valid: False, node: 665, tag: div, level: 17" node_number="665"><div title="valid: False, node: 666, tag: div, level: 18" node_number="666"><a title="valid: False, node: 667, tag: a, level: 19" node_number="667">Crossref</a></div><div title="valid: False, node: 668, tag: div, level: 18" node_number="668"><a title="valid: False, node: 669, tag: a, level: 19" node_number="669">PubMed</a></div><div title="valid: False, node: 670, tag: div, level: 18" node_number="670"><a title="valid: False, node: 671, tag: a, level: 19" node_number="671">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 672, tag: div, level: 14" node_number="672"><div title="valid: False, node: 673, tag: div, level: 15" node_number="673">36</div><div title="valid: False, node: 674, tag: div, level: 15" node_number="674"><div title="valid: False, node: 675, tag: div, level: 16" node_number="675"><div title="valid: False, node: 676, tag: div, level: 17" node_number="676">T. Giavridis, S. J. C. van der Stegen, J. Eyquem, M. Hamieh, A. Piersigilli, M. Sadelain, CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat. Med. <b title="valid: False, node: 677, tag: b, level: 18" node_number="677">24</b>, 731&#8211;738 (2018).</div><div title="valid: False, node: 678, tag: div, level: 17" node_number="678"><div title="valid: False, node: 679, tag: div, level: 18" node_number="679"><a title="valid: False, node: 680, tag: a, level: 19" node_number="680">Crossref</a></div><div title="valid: False, node: 681, tag: div, level: 18" node_number="681"><a title="valid: False, node: 682, tag: a, level: 19" node_number="682">PubMed</a></div><div title="valid: False, node: 683, tag: div, level: 18" node_number="683"><a title="valid: False, node: 684, tag: a, level: 19" node_number="684">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 685, tag: div, level: 14" node_number="685"><div title="valid: False, node: 686, tag: div, level: 15" node_number="686">37</div><div title="valid: False, node: 687, tag: div, level: 15" node_number="687"><div title="valid: False, node: 688, tag: div, level: 16" node_number="688"><div title="valid: False, node: 689, tag: div, level: 17" node_number="689">M. Norelli, B. Camisa, G. Barbiera, L. Falcone, A. Purevdorj, M. Genua, F. Sanvito, M. Ponzoni, C. Doglioni, P. Cristofori, C. Traversari, C. Bordignon, F. Ciceri, R. Ostuni, C. Bonini, M. Casucci, A. Bondanza, Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat. Med. <b title="valid: False, node: 690, tag: b, level: 18" node_number="690">24</b>, 739&#8211;748 (2018).</div><div title="valid: False, node: 691, tag: div, level: 17" node_number="691"><div title="valid: False, node: 692, tag: div, level: 18" node_number="692"><a title="valid: False, node: 693, tag: a, level: 19" node_number="693">Crossref</a></div><div title="valid: False, node: 694, tag: div, level: 18" node_number="694"><a title="valid: False, node: 695, tag: a, level: 19" node_number="695">PubMed</a></div><div title="valid: False, node: 696, tag: div, level: 18" node_number="696"><a title="valid: False, node: 697, tag: a, level: 19" node_number="697">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 698, tag: div, level: 14" node_number="698"><div title="valid: False, node: 699, tag: div, level: 15" node_number="699">38</div><div title="valid: False, node: 700, tag: div, level: 15" node_number="700"><div title="valid: False, node: 701, tag: div, level: 16" node_number="701"><div title="valid: False, node: 702, tag: div, level: 17" node_number="702">M. E. Pipkin, J. A. Sacks, F. Cruz-Guilloty, M. G. Lichtenheld, M. J. Bevan, A. Rao, Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity <b title="valid: False, node: 703, tag: b, level: 18" node_number="703">32</b>, 79&#8211;90 (2010).</div><div title="valid: False, node: 704, tag: div, level: 17" node_number="704"><div title="valid: False, node: 705, tag: div, level: 18" node_number="705"><a title="valid: False, node: 706, tag: a, level: 19" node_number="706">Crossref</a></div><div title="valid: False, node: 707, tag: div, level: 18" node_number="707"><a title="valid: False, node: 708, tag: a, level: 19" node_number="708">PubMed</a></div><div title="valid: False, node: 709, tag: div, level: 18" node_number="709"><a title="valid: False, node: 710, tag: a, level: 19" node_number="710">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 711, tag: div, level: 14" node_number="711"><div title="valid: False, node: 712, tag: div, level: 15" node_number="712">39</div><div title="valid: False, node: 713, tag: div, level: 15" node_number="713"><div title="valid: False, node: 714, tag: div, level: 16" node_number="714"><div title="valid: False, node: 715, tag: div, level: 17" node_number="715">K. Lorre, L. Fransen, J. L. Ceuppens, Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway. Eur. Cytokine Netw. <b title="valid: False, node: 716, tag: b, level: 18" node_number="716">3</b>, 321&#8211;330 (1992).</div><div title="valid: False, node: 717, tag: div, level: 17" node_number="717"><div title="valid: False, node: 718, tag: div, level: 18" node_number="718"><a title="valid: False, node: 719, tag: a, level: 19" node_number="719">PubMed</a></div><div title="valid: False, node: 720, tag: div, level: 18" node_number="720"><a title="valid: False, node: 721, tag: a, level: 19" node_number="721">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 722, tag: div, level: 14" node_number="722"><div title="valid: False, node: 723, tag: div, level: 15" node_number="723">40</div><div title="valid: False, node: 724, tag: div, level: 15" node_number="724"><div title="valid: False, node: 725, tag: div, level: 16" node_number="725"><div title="valid: False, node: 726, tag: div, level: 17" node_number="726">A. Ythier, M. P. Gascon, P. Juillard, C. Vesin, D. Wallach, G. E. Grau, Protective effect of natural TNF-binding protein on human TNF-induced toxicity in mice. Cytokine <b title="valid: False, node: 727, tag: b, level: 18" node_number="727">5</b>, 459&#8211;462 (1993).</div><div title="valid: False, node: 728, tag: div, level: 17" node_number="728"><div title="valid: False, node: 729, tag: div, level: 18" node_number="729"><a title="valid: False, node: 730, tag: a, level: 19" node_number="730">Crossref</a></div><div title="valid: False, node: 731, tag: div, level: 18" node_number="731"><a title="valid: False, node: 732, tag: a, level: 19" node_number="732">PubMed</a></div><div title="valid: False, node: 733, tag: div, level: 18" node_number="733"><a title="valid: False, node: 734, tag: a, level: 19" node_number="734">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 735, tag: div, level: 14" node_number="735"><div title="valid: False, node: 736, tag: div, level: 15" node_number="736">41</div><div title="valid: False, node: 737, tag: div, level: 15" node_number="737"><div title="valid: False, node: 738, tag: div, level: 16" node_number="738"><div title="valid: False, node: 739, tag: div, level: 17" node_number="739">P. Strati, S. Ahmed, P. Kebriaei, L. I. Nastoupil, C. M. Claussen, G. Watson, S. B. Horowitz, A. R. T. Brown, B. Do, M. A. Rodriguez, R. Nair, E. J. Shpall, M. R. Green, S. S. Neelapu, J. R. Westin, Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma. Blood Adv. <b title="valid: False, node: 740, tag: b, level: 18" node_number="740">4</b>, 3123&#8211;3127 (2020).</div><div title="valid: False, node: 741, tag: div, level: 17" node_number="741"><div title="valid: False, node: 742, tag: div, level: 18" node_number="742"><a title="valid: False, node: 743, tag: a, level: 19" node_number="743">Crossref</a></div><div title="valid: False, node: 744, tag: div, level: 18" node_number="744"><a title="valid: False, node: 745, tag: a, level: 19" node_number="745">PubMed</a></div><div title="valid: False, node: 746, tag: div, level: 18" node_number="746"><a title="valid: False, node: 747, tag: a, level: 19" node_number="747">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 748, tag: div, level: 14" node_number="748"><div title="valid: False, node: 749, tag: div, level: 15" node_number="749">42</div><div title="valid: False, node: 750, tag: div, level: 15" node_number="750"><div title="valid: False, node: 751, tag: div, level: 16" node_number="751"><div title="valid: False, node: 752, tag: div, level: 17" node_number="752">S. L. Maude, D. Barrett, D. T. Teachey, S. A. Grupp, Managing cytokine release syndrome associated with novel T cell-engaging therapies. Cancer J. <b title="valid: False, node: 753, tag: b, level: 18" node_number="753">20</b>, 119&#8211;122 (2014).</div><div title="valid: False, node: 754, tag: div, level: 17" node_number="754"><div title="valid: False, node: 755, tag: div, level: 18" node_number="755"><a title="valid: False, node: 756, tag: a, level: 19" node_number="756">Crossref</a></div><div title="valid: False, node: 757, tag: div, level: 18" node_number="757"><a title="valid: False, node: 758, tag: a, level: 19" node_number="758">PubMed</a></div><div title="valid: False, node: 759, tag: div, level: 18" node_number="759"><a title="valid: False, node: 760, tag: a, level: 19" node_number="760">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 761, tag: div, level: 14" node_number="761"><div title="valid: False, node: 762, tag: div, level: 15" node_number="762">43</div><div title="valid: False, node: 763, tag: div, level: 15" node_number="763"><div title="valid: False, node: 764, tag: div, level: 16" node_number="764"><div title="valid: False, node: 765, tag: div, level: 17" node_number="765">C. Waugh, L. Sinclair, D. Finlay, J. R. Bayascas, D. Cantrell, Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation. Mol. Cell. Biol. <b title="valid: False, node: 766, tag: b, level: 18" node_number="766">29</b>, 5952&#8211;5962 (2009).</div><div title="valid: False, node: 767, tag: div, level: 17" node_number="767"><div title="valid: False, node: 768, tag: div, level: 18" node_number="768"><a title="valid: False, node: 769, tag: a, level: 19" node_number="769">Crossref</a></div><div title="valid: False, node: 770, tag: div, level: 18" node_number="770"><a title="valid: False, node: 771, tag: a, level: 19" node_number="771">PubMed</a></div><div title="valid: False, node: 772, tag: div, level: 18" node_number="772"><a title="valid: False, node: 773, tag: a, level: 19" node_number="773">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 774, tag: div, level: 14" node_number="774"><div title="valid: False, node: 775, tag: div, level: 15" node_number="775">44</div><div title="valid: False, node: 776, tag: div, level: 15" node_number="776"><div title="valid: False, node: 777, tag: div, level: 16" node_number="777"><div title="valid: False, node: 778, tag: div, level: 17" node_number="778">V. Mirenda, S. J. Jarmin, R. David, J. Dyson, D. Scott, Y. Gu, R. I. Lechler, K. Okkenhaug, F. M. Marelli-Berg, Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood <b title="valid: False, node: 779, tag: b, level: 18" node_number="779">109</b>, 2968&#8211;2977 (2007).</div><div title="valid: False, node: 780, tag: div, level: 17" node_number="780"><div title="valid: False, node: 781, tag: div, level: 18" node_number="781"><a title="valid: False, node: 782, tag: a, level: 19" node_number="782">Crossref</a></div><div title="valid: False, node: 783, tag: div, level: 18" node_number="783"><a title="valid: False, node: 784, tag: a, level: 19" node_number="784">PubMed</a></div><div title="valid: False, node: 785, tag: div, level: 18" node_number="785"><a title="valid: False, node: 786, tag: a, level: 19" node_number="786">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 787, tag: div, level: 14" node_number="787"><div title="valid: False, node: 788, tag: div, level: 15" node_number="788">45</div><div title="valid: False, node: 789, tag: div, level: 15" node_number="789"><div title="valid: False, node: 790, tag: div, level: 16" node_number="790"><div title="valid: False, node: 791, tag: div, level: 17" node_number="791">J. N. Blattman, J. M. Grayson, E. J. Wherry, S. M. Kaech, K. A. Smith, R. Ahmed, Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. <b title="valid: False, node: 792, tag: b, level: 18" node_number="792">9</b>, 540&#8211;547 (2003).</div><div title="valid: False, node: 793, tag: div, level: 17" node_number="793"><div title="valid: False, node: 794, tag: div, level: 18" node_number="794"><a title="valid: False, node: 795, tag: a, level: 19" node_number="795">Crossref</a></div><div title="valid: False, node: 796, tag: div, level: 18" node_number="796"><a title="valid: False, node: 797, tag: a, level: 19" node_number="797">PubMed</a></div><div title="valid: False, node: 798, tag: div, level: 18" node_number="798"><a title="valid: False, node: 799, tag: a, level: 19" node_number="799">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 800, tag: div, level: 14" node_number="800"><div title="valid: False, node: 801, tag: div, level: 15" node_number="801">46</div><div title="valid: False, node: 802, tag: div, level: 15" node_number="802"><div title="valid: False, node: 803, tag: div, level: 16" node_number="803"><div title="valid: False, node: 804, tag: div, level: 17" node_number="804">P. J. Aspuria, S. Vivona, M. Bauer, M. Semana, N. Ratti, S. M. Cauley, R. Riener, R. de Waal Malefyt, D. Rokkam, J. Emmerich, R. A. Kastelein, P. J. Lupardus, M. Oft, An orthogonal IL-2 and IL-2R&#946; system drives persistence and activation of CAR T cells and clearance of bulky lymphoma. Sci. Transl. Med. <b title="valid: False, node: 805, tag: b, level: 18" node_number="805">13</b>, eabg7565 (2021).</div><div title="valid: False, node: 806, tag: div, level: 17" node_number="806"><div title="valid: False, node: 807, tag: div, level: 18" node_number="807"><a title="valid: False, node: 808, tag: a, level: 19" node_number="808">Crossref</a></div><div title="valid: False, node: 809, tag: div, level: 18" node_number="809"><a title="valid: False, node: 810, tag: a, level: 19" node_number="810">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 811, tag: div, level: 14" node_number="811"><div title="valid: False, node: 812, tag: div, level: 15" node_number="812">47</div><div title="valid: False, node: 813, tag: div, level: 15" node_number="813"><div title="valid: False, node: 814, tag: div, level: 16" node_number="814"><div title="valid: False, node: 815, tag: div, level: 17" node_number="815">M. C. Milone, J. D. Fish, C. Carpenito, R. G. Carroll, G. K. Binder, D. Teachey, M. Samanta, M. Lakhal, B. Gloss, G. Danet-Desnoyers, D. Campana, J. L. Riley, S. A. Grupp, C. H. June, Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther. <b title="valid: False, node: 816, tag: b, level: 18" node_number="816">17</b>, 1453&#8211;1464 (2009).</div><div title="valid: False, node: 817, tag: div, level: 17" node_number="817"><div title="valid: False, node: 818, tag: div, level: 18" node_number="818"><a title="valid: False, node: 819, tag: a, level: 19" node_number="819">Crossref</a></div><div title="valid: False, node: 820, tag: div, level: 18" node_number="820"><a title="valid: False, node: 821, tag: a, level: 19" node_number="821">PubMed</a></div><div title="valid: False, node: 822, tag: div, level: 18" node_number="822"><a title="valid: False, node: 823, tag: a, level: 19" node_number="823">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 824, tag: div, level: 14" node_number="824"><div title="valid: False, node: 825, tag: div, level: 15" node_number="825">48</div><div title="valid: False, node: 826, tag: div, level: 15" node_number="826"><div title="valid: False, node: 827, tag: div, level: 16" node_number="827"><div title="valid: False, node: 828, tag: div, level: 17" node_number="828">G. Chao, W. L. Lau, B. J. Hackel, S. L. Sazinsky, S. M. Lippow, K. D. Wittrup, Isolating and engineering human antibodies using yeast surface display. Nat. Protoc. <b title="valid: False, node: 829, tag: b, level: 18" node_number="829">1</b>, 755&#8211;768 (2006).</div><div title="valid: False, node: 830, tag: div, level: 17" node_number="830"><div title="valid: False, node: 831, tag: div, level: 18" node_number="831"><a title="valid: False, node: 832, tag: a, level: 19" node_number="832">Crossref</a></div><div title="valid: False, node: 833, tag: div, level: 18" node_number="833"><a title="valid: False, node: 834, tag: a, level: 19" node_number="834">PubMed</a></div><div title="valid: False, node: 835, tag: div, level: 18" node_number="835"><a title="valid: False, node: 836, tag: a, level: 19" node_number="836">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 837, tag: div, level: 14" node_number="837"><div title="valid: False, node: 838, tag: div, level: 15" node_number="838">49</div><div title="valid: False, node: 839, tag: div, level: 15" node_number="839"><div title="valid: False, node: 840, tag: div, level: 16" node_number="840"><div title="valid: False, node: 841, tag: div, level: 17" node_number="841">J. Bryant, R. Day, T. L. Whiteside, R. B. Herberman, Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Methods <b title="valid: False, node: 842, tag: b, level: 18" node_number="842">146</b>, 91&#8211;103 (1992).</div><div title="valid: False, node: 843, tag: div, level: 17" node_number="843"><div title="valid: False, node: 844, tag: div, level: 18" node_number="844"><a title="valid: False, node: 845, tag: a, level: 19" node_number="845">Crossref</a></div><div title="valid: False, node: 846, tag: div, level: 18" node_number="846"><a title="valid: False, node: 847, tag: a, level: 19" node_number="847">PubMed</a></div><div title="valid: False, node: 848, tag: div, level: 18" node_number="848"><a title="valid: False, node: 849, tag: a, level: 19" node_number="849">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 850, tag: div, level: 14" node_number="850"><div title="valid: False, node: 851, tag: div, level: 15" node_number="851">50</div><div title="valid: False, node: 852, tag: div, level: 15" node_number="852"><div title="valid: False, node: 853, tag: div, level: 16" node_number="853"><div title="valid: False, node: 854, tag: div, level: 17" node_number="854">B. Kittel, C. Ruehl-Fehlert, G. Morawietz, J. Klapwijk, M. R. Elwell, B. Lenz, M. G. O&#8217;Sullivan, D. R. Roth, P. F. Wadsworth, Revised guides for organ sampling and trimming in rats and mice&#8212;Part 2. A joint publication of the RITA and NACAD groups. Exp. Toxicol. Pathol. <b title="valid: False, node: 855, tag: b, level: 18" node_number="855">55</b>, 413&#8211;431 (2004).</div><div title="valid: False, node: 856, tag: div, level: 17" node_number="856"><div title="valid: False, node: 857, tag: div, level: 18" node_number="857"><a title="valid: False, node: 858, tag: a, level: 19" node_number="858">Crossref</a></div><div title="valid: False, node: 859, tag: div, level: 18" node_number="859"><a title="valid: False, node: 860, tag: a, level: 19" node_number="860">PubMed</a></div><div title="valid: False, node: 861, tag: div, level: 18" node_number="861"><a title="valid: False, node: 862, tag: a, level: 19" node_number="862">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 863, tag: div, level: 14" node_number="863"><div title="valid: False, node: 864, tag: div, level: 15" node_number="864">51</div><div title="valid: False, node: 865, tag: div, level: 15" node_number="865"><div title="valid: False, node: 866, tag: div, level: 16" node_number="866"><div title="valid: False, node: 867, tag: div, level: 17" node_number="867">G. Morawietz, C. Ruehl-Fehlert, B. Kittel, A. Bube, K. Keane, S. Halm, A. Heuser, J. Hellmann, Revised guides for organ sampling and trimming in rats and mice&#8212;Part 3. A joint publication of the RITA and NACAD groups. Exp. Toxicol. Pathol. <b title="valid: False, node: 868, tag: b, level: 18" node_number="868">55</b>, 433&#8211;449 (2004).</div><div title="valid: False, node: 869, tag: div, level: 17" node_number="869"><div title="valid: False, node: 870, tag: div, level: 18" node_number="870"><a title="valid: False, node: 871, tag: a, level: 19" node_number="871">Crossref</a></div><div title="valid: False, node: 872, tag: div, level: 18" node_number="872"><a title="valid: False, node: 873, tag: a, level: 19" node_number="873">PubMed</a></div><div title="valid: False, node: 874, tag: div, level: 18" node_number="874"><a title="valid: False, node: 875, tag: a, level: 19" node_number="875">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 876, tag: div, level: 14" node_number="876"><div title="valid: False, node: 877, tag: div, level: 15" node_number="877">52</div><div title="valid: False, node: 878, tag: div, level: 15" node_number="878"><div title="valid: False, node: 879, tag: div, level: 16" node_number="879"><div title="valid: False, node: 880, tag: div, level: 17" node_number="880">C. Ruehl-Fehlert, B. Kittel, G. Morawietz, P. Deslex, C. Keenan, C. R. Mahrt, T. Nolte, M. Robinson, B. P. Stuart, U. Deschl, Revised guides for organ sampling and trimming in rats and mice&#8212;Part 1: A joint publication of the RITA and NACAD groups. Exp. Toxicol. Pathol. <b title="valid: False, node: 881, tag: b, level: 18" node_number="881">55</b>, 91&#8211;106 (2003).</div><div title="valid: False, node: 882, tag: div, level: 17" node_number="882"><div title="valid: False, node: 883, tag: div, level: 18" node_number="883"><a title="valid: False, node: 884, tag: a, level: 19" node_number="884">Crossref</a></div><div title="valid: False, node: 885, tag: div, level: 18" node_number="885"><a title="valid: False, node: 886, tag: a, level: 19" node_number="886">PubMed</a></div><div title="valid: False, node: 887, tag: div, level: 18" node_number="887"><a title="valid: False, node: 888, tag: a, level: 19" node_number="888">Google Scholar</a></div></div></div></div></div></section></div></section><div class="valid" valid="valid" title="valid: True, node: 889, tag: div, level: 11" node_number="889"><div class="valid" valid="valid" title="valid: True, node: 890, tag: div, level: 12" node_number="890"><header class="valid" valid="valid" title="valid: True, node: 891, tag: header, level: 13" node_number="891"><h2 class="valid" valid="valid" title="valid: True, node: 892, tag: h2, level: 14" node_number="892">Information Authors</h2></header><section class="valid" valid="valid" title="valid: True, node: 893, tag: section, level: 13" node_number="893"><h3 class="valid" valid="valid" title="valid: True, node: 894, tag: h3, level: 14" node_number="894">Information</h3><section class="valid" valid="valid" title="valid: True, node: 895, tag: section, level: 14" node_number="895"><h4 title="valid: False, node: 896, tag: h4, level: 15" node_number="896">Published In</h4><div title="valid: False, node: 897, tag: div, level: 15" node_number="897"> <div title="valid: False, node: 898, tag: div, level: 16" node_number="898"><div title="valid: False, node: 899, tag: div, level: 17" node_number="899">Science Translational Medicine</div><div title="valid: False, node: 900, tag: div, level: 17" node_number="900">Volume 13 | Issue 625December 2021</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 901, tag: section, level: 14" node_number="901"><h4 title="valid: False, node: 902, tag: h4, level: 15" node_number="902">Copyright</h4><div title="valid: False, node: 903, tag: div, level: 15" node_number="903">Copyright &#169; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</div><div title="valid: False, node: 904, tag: div, level: 15" node_number="904">https://www.sciencemag.org/about/science-licenses-journal-article-reuse</div><div title="valid: False, node: 905, tag: div, level: 15" node_number="905">This is an article distributed under the terms of the Science Journals Default License.</div></section><section class="valid" valid="valid" title="valid: True, node: 906, tag: section, level: 14" node_number="906"><h4 title="valid: False, node: 907, tag: h4, level: 15" node_number="907">Submission history</h4><div title="valid: False, node: 908, tag: div, level: 15" node_number="908"><b title="valid: False, node: 909, tag: b, level: 16" node_number="909">Received</b>: 22 January 2021</div><div title="valid: False, node: 910, tag: div, level: 15" node_number="910"><b title="valid: False, node: 911, tag: b, level: 16" node_number="911">Accepted</b>: 14 October 2021</div></section><section class="valid" valid="valid" title="valid: True, node: 912, tag: section, level: 14" node_number="912"><h4 title="valid: False, node: 913, tag: h4, level: 15" node_number="913">Permissions</h4><div title="valid: False, node: 914, tag: div, level: 15" node_number="914">Request permissions for this article.</div><div title="valid: False, node: 915, tag: div, level: 15" node_number="915"><a title="valid: False, node: 916, tag: a, level: 16" node_number="916">Request Permissions</a></div></section><section class="valid" valid="valid" title="valid: True, node: 917, tag: section, level: 14" node_number="917"><h4 title="valid: False, node: 918, tag: h4, level: 15" node_number="918">Acknowledgments</h4><div title="valid: False, node: 919, tag: div, level: 15" node_number="919">We thank the members of the following facilities at the University of Pennsylvania: the Flow Cytometry Core for cell sorting, the Human Immunology Core for providing T cells from normal donors, the Translational and Correlative Studies Laboratory for performing Luminex Assays, the Laboratory Animal Resources, the Stem Cell and Xenograft Core for the tumor and CAR T cell injections and drawing blood from mice, and the Comparative Pathology Core for immunohistochemistry, image acquisition, and analysis. We thank M. A. Wasik in the Fox Chase Cancer Center for providing SeAx cells. We also thank F. Lang, J. Leferovich, and J. Han Noll for assistance with in the vivo experiments.</div><div title="valid: False, node: 920, tag: div, level: 15" node_number="920"><b title="valid: False, node: 921, tag: b, level: 16" node_number="921">Funding:</b> The research reported in this publication was supported by grants from NIH National Cancer Institute (U54CA244711 to M.C.M. and K.C.G.) and institutional funds of the University of Pennsylvania. The Penn Vet Comparative Pathology Core is supported by the Abramson Cancer Center Support Grant (P30 CA016520). The scanner used for whole slide imaging was supported by an NIH Shared Instrumentation Grant (S10 OD023465-01A1 to the Penn Vet Comparative Pathology Core). K.C.G. is an Investigator of the Howard Hughes Medical Institute and supported by Ludwig Foundation and Parker Institute for Cancer Immunotherapy (U54CA244711 and RO1-AI51321).</div><div title="valid: False, node: 922, tag: div, level: 15" node_number="922"><b title="valid: False, node: 923, tag: b, level: 16" node_number="923">Author contributions:</b> Q.Z. designed the project, oversaw and performed the experiments, analyzed the data, and wrote the manuscript. M.E.H., L.K.P., L.S., J.T.S., M.J.H., and J.T.S. conducted and analyzed the in vitro and in vivo experiments and data. K.C.G. and J.T.S. designed the <i title="valid: False, node: 924, tag: i, level: 16" node_number="924">ortho</i>-IL-2/<i title="valid: False, node: 925, tag: i, level: 16" node_number="925">ortho</i>-IL-2R&#946; system and provided human <i title="valid: False, node: 926, tag: i, level: 16" node_number="926">ortho-</i>IL-2. L.S. performed in vitro functional characterization of the <i title="valid: False, node: 927, tag: i, level: 16" node_number="927">ortho</i>-IL-2/<i title="valid: False, node: 928, tag: i, level: 16" node_number="928">ortho</i>-IL-2R&#946; system. L.K.P. provided recombinant <i title="valid: False, node: 929, tag: i, level: 16" node_number="929">ortho</i>-IL-2 for in vivo studies. S.N.-C. helped in vivo experiments. Z.Z. performed in vivo experiments. M.C.M. conceived and designed the study, oversaw the project, and contributed to data analysis and editing of the final version of the manuscript. All authors approved the final version of the manuscript.</div><div title="valid: False, node: 930, tag: div, level: 15" node_number="930"><b title="valid: False, node: 931, tag: b, level: 16" node_number="931">Competing interests:</b> M.C.M. is an inventor of CAR T cell technology used in these studies (Methods for treatment of cancer, U.S. patent no. 8,906,682). This technology is owned by the University of Pennsylvania and licensed to Novartis AG. K.C.G. is the Founder of Synthekine Therapeutics, which has licensed the ortho-2 technology. K.C.G., J.T.S., L.S., and L.K.P. are inventors on a patent application describing the ortho-2 system (Biologically relevant orthogonal cytokine/receptor pairs, U.S. patent no. 10,869,887B2). K.C.G., J.T.S., L.S., and L.K.P. are shareholders of Synthekine, a biotechnology company that has licensed the <i title="valid: False, node: 932, tag: i, level: 16" node_number="932">ortho-</i>IL-2 technology. The remaining authors declare no competing financial interests.</div><div title="valid: False, node: 933, tag: div, level: 15" node_number="933"><b title="valid: False, node: 934, tag: b, level: 16" node_number="934">Data and materials availability:</b> All data associated with this study are present in the paper or the Supplementary Materials. A material transfer agreement will be required for the sharing of materials used in these studies. Requests for materials should be sent to either M.C.M. (<a title="valid: False, node: 935, tag: a, level: 16" node_number="935">[email&#160;protected]</a>) or K.C.G. (<a title="valid: False, node: 936, tag: a, level: 16" node_number="936">[email&#160;protected]</a>).</div></section></section><section class="valid" valid="valid" title="valid: True, node: 937, tag: section, level: 13" node_number="937"><h3 class="valid" valid="valid" title="valid: True, node: 938, tag: h3, level: 14" node_number="938">Authors</h3><section class="valid" valid="valid" title="valid: True, node: 939, tag: section, level: 14" node_number="939"><h4 title="valid: False, node: 940, tag: h4, level: 15" node_number="940">Affiliations</h4><div title="valid: False, node: 941, tag: div, level: 15" node_number="941"><div title="valid: False, node: 942, tag: div, level: 16" node_number="942">Qian Zhang https://orcid.org/0000-0002-2858-0962</div><div title="valid: False, node: 943, tag: div, level: 16" node_number="943"><div title="valid: False, node: 944, tag: div, level: 17" node_number="944"><div title="valid: False, node: 945, tag: div, level: 18" node_number="945">Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div title="valid: False, node: 946, tag: div, level: 17" node_number="946">View all articles by this author</div></div></div><div title="valid: False, node: 947, tag: div, level: 15" node_number="947"><div title="valid: False, node: 948, tag: div, level: 16" node_number="948">Morgan E. Hresko https://orcid.org/0000-0003-1322-3791</div><div title="valid: False, node: 949, tag: div, level: 16" node_number="949"><div title="valid: False, node: 950, tag: div, level: 17" node_number="950"><div title="valid: False, node: 951, tag: div, level: 18" node_number="951">Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div title="valid: False, node: 952, tag: div, level: 17" node_number="952">View all articles by this author</div></div></div><div title="valid: False, node: 953, tag: div, level: 15" node_number="953"><div title="valid: False, node: 954, tag: div, level: 16" node_number="954">Lora K. Picton https://orcid.org/0000-0002-0482-5187</div><div title="valid: False, node: 955, tag: div, level: 16" node_number="955"><div title="valid: False, node: 956, tag: div, level: 17" node_number="956"><div title="valid: False, node: 957, tag: div, level: 18" node_number="957">Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div title="valid: False, node: 958, tag: div, level: 17" node_number="958">View all articles by this author</div></div></div><div title="valid: False, node: 959, tag: div, level: 15" node_number="959"><div title="valid: False, node: 960, tag: div, level: 16" node_number="960">Leon Su https://orcid.org/0000-0001-7654-9997</div><div title="valid: False, node: 961, tag: div, level: 16" node_number="961"><div title="valid: False, node: 962, tag: div, level: 17" node_number="962"><div title="valid: False, node: 963, tag: div, level: 18" node_number="963">Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div title="valid: False, node: 964, tag: div, level: 17" node_number="964">View all articles by this author</div></div></div><div title="valid: False, node: 965, tag: div, level: 15" node_number="965"><div title="valid: False, node: 966, tag: div, level: 16" node_number="966">Michael J. Hollander https://orcid.org/0000-0002-3108-2788</div><div title="valid: False, node: 967, tag: div, level: 16" node_number="967"><div title="valid: False, node: 968, tag: div, level: 17" node_number="968"><div title="valid: False, node: 969, tag: div, level: 18" node_number="969">Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div title="valid: False, node: 970, tag: div, level: 17" node_number="970">View all articles by this author</div></div></div><div title="valid: False, node: 971, tag: div, level: 15" node_number="971"><div title="valid: False, node: 972, tag: div, level: 16" node_number="972">Selene Nunez-Cruz</div><div title="valid: False, node: 973, tag: div, level: 16" node_number="973"><div title="valid: False, node: 974, tag: div, level: 17" node_number="974"><div title="valid: False, node: 975, tag: div, level: 18" node_number="975">Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div title="valid: False, node: 976, tag: div, level: 17" node_number="976">View all articles by this author</div></div></div><div title="valid: False, node: 977, tag: div, level: 15" node_number="977"><div title="valid: False, node: 978, tag: div, level: 16" node_number="978">Zheng Zhang https://orcid.org/0000-0002-3242-5738</div><div title="valid: False, node: 979, tag: div, level: 16" node_number="979"><div title="valid: False, node: 980, tag: div, level: 17" node_number="980"><div title="valid: False, node: 981, tag: div, level: 18" node_number="981">Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div title="valid: False, node: 982, tag: div, level: 17" node_number="982">View all articles by this author</div></div></div><div title="valid: False, node: 983, tag: div, level: 15" node_number="983"><div title="valid: False, node: 984, tag: div, level: 16" node_number="984">Charles-Antoine Assenmacher https://orcid.org/0000-0003-0073-2730</div><div title="valid: False, node: 985, tag: div, level: 16" node_number="985"><div title="valid: False, node: 986, tag: div, level: 17" node_number="986"><div title="valid: False, node: 987, tag: div, level: 18" node_number="987">Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104, USA.</div></div><div title="valid: False, node: 988, tag: div, level: 17" node_number="988">View all articles by this author</div></div></div><div title="valid: False, node: 989, tag: div, level: 15" node_number="989"><div title="valid: False, node: 990, tag: div, level: 16" node_number="990">Jonathan T. Sockolosky https://orcid.org/0000-0002-5441-1409</div><div title="valid: False, node: 991, tag: div, level: 16" node_number="991"><div title="valid: False, node: 992, tag: div, level: 17" node_number="992"><div title="valid: False, node: 993, tag: div, level: 18" node_number="993">Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div title="valid: False, node: 994, tag: div, level: 17" node_number="994"><div title="valid: False, node: 995, tag: div, level: 18" node_number="995">Present address: Department of Antibody Engineering, Genentech Inc., 1 DNA Way, South San Francisco, CA 94090, USA.</div></div><div title="valid: False, node: 996, tag: div, level: 17" node_number="996">View all articles by this author</div></div></div><div title="valid: False, node: 997, tag: div, level: 15" node_number="997"><div title="valid: False, node: 998, tag: div, level: 16" node_number="998">K. Christopher Garcia<sup title="valid: False, node: 999, tag: sup, level: 17" node_number="999">*</sup> https://orcid.org/0000-0001-9273-0278 [email&#160;protected]</div><div title="valid: False, node: 1000, tag: div, level: 16" node_number="1000"><div title="valid: False, node: 1001, tag: div, level: 17" node_number="1001"><div title="valid: False, node: 1002, tag: div, level: 18" node_number="1002">Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.</div><div title="valid: False, node: 1003, tag: div, level: 18" node_number="1003">Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.</div></div><div title="valid: False, node: 1004, tag: div, level: 17" node_number="1004">View all articles by this author</div></div></div><div title="valid: False, node: 1005, tag: div, level: 15" node_number="1005"><div title="valid: False, node: 1006, tag: div, level: 16" node_number="1006">Michael C. Milone<sup title="valid: False, node: 1007, tag: sup, level: 17" node_number="1007">*</sup> https://orcid.org/0000-0002-1580-9844 [email&#160;protected]</div><div title="valid: False, node: 1008, tag: div, level: 16" node_number="1008"><div title="valid: False, node: 1009, tag: div, level: 17" node_number="1009"><div title="valid: False, node: 1010, tag: div, level: 18" node_number="1010">Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</div></div><div title="valid: False, node: 1011, tag: div, level: 17" node_number="1011">View all articles by this author</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1012, tag: section, level: 14" node_number="1012"><h4 title="valid: False, node: 1013, tag: h4, level: 15" node_number="1013">Funding Information</h4><div title="valid: False, node: 1014, tag: div, level: 15" node_number="1014">National Institutes of Health: U54CA244711</div><div title="valid: False, node: 1015, tag: div, level: 15" node_number="1015"><a title="valid: False, node: 1016, tag: a, level: 16" node_number="1016">National Institutes of Health</a>: S10 OD023465-01A1</div><div title="valid: False, node: 1017, tag: div, level: 15" node_number="1017"><a title="valid: False, node: 1018, tag: a, level: 16" node_number="1018">National Institutes of Health</a>: </div><div title="valid: False, node: 1019, tag: div, level: 15" node_number="1019"><a title="valid: False, node: 1020, tag: a, level: 16" node_number="1020">Howard Hughes Medical Institute</a>: U54CA244711</div><div title="valid: False, node: 1021, tag: div, level: 15" node_number="1021"><a title="valid: False, node: 1022, tag: a, level: 16" node_number="1022">Howard Hughes Medical Institute</a>: RO1-AI51321</div><div title="valid: False, node: 1023, tag: div, level: 15" node_number="1023"><a title="valid: False, node: 1024, tag: a, level: 16" node_number="1024">University of Pennsvlvania</a>: </div><div title="valid: False, node: 1025, tag: div, level: 15" node_number="1025"><a title="valid: False, node: 1026, tag: a, level: 16" node_number="1026">University of Pennsvlvania</a>: S10 OD023465-01A1</div><div title="valid: False, node: 1027, tag: div, level: 15" node_number="1027"><a title="valid: False, node: 1028, tag: a, level: 16" node_number="1028">Parker Institute for Cancer Immunotherapy</a>: </div><div title="valid: False, node: 1029, tag: div, level: 15" node_number="1029"><a title="valid: False, node: 1030, tag: a, level: 16" node_number="1030">Parker Institute for Cancer Immunotherapy</a>: U54CA244711</div><div title="valid: False, node: 1031, tag: div, level: 15" node_number="1031"><a title="valid: False, node: 1032, tag: a, level: 16" node_number="1032">Parker Institute for Cancer Immunotherapy</a>: RO1-AI51321</div><div title="valid: False, node: 1033, tag: div, level: 15" node_number="1033"><a title="valid: False, node: 1034, tag: a, level: 16" node_number="1034">UVA Cancer Center</a>: </div><div title="valid: False, node: 1035, tag: div, level: 15" node_number="1035"><a title="valid: False, node: 1036, tag: a, level: 16" node_number="1036">Cancer Center, University of Florida Health</a>: P30 CA016520</div><div title="valid: False, node: 1037, tag: div, level: 15" node_number="1037"><a title="valid: False, node: 1038, tag: a, level: 16" node_number="1038">Cancer Center, University of Florida Health</a>: </div><div title="valid: False, node: 1039, tag: div, level: 15" node_number="1039">NIH National Cancer Institute and institutional funds of the University of Pennsylvania: U54CA244711</div><div title="valid: False, node: 1040, tag: div, level: 15" node_number="1040"><a title="valid: False, node: 1041, tag: a, level: 16" node_number="1041">UVA Cancer Center</a>: P30 CA016520</div></section><section class="valid" valid="valid" title="valid: True, node: 1042, tag: section, level: 14" node_number="1042"><h4 title="valid: False, node: 1043, tag: h4, level: 15" node_number="1043">Notes</h4><div title="valid: False, node: 1044, tag: div, level: 15" node_number="1044">*Corresponding author. Email: <a title="valid: False, node: 1045, tag: a, level: 16" node_number="1045">[email&#160;protected]</a> (M.C.M.); <a title="valid: False, node: 1046, tag: a, level: 16" node_number="1046">[email&#160;protected]</a> (K.C.G.)</div></section></section></div><div class="valid" valid="valid" title="valid: True, node: 1047, tag: div, level: 12" node_number="1047"><header class="valid" valid="valid" title="valid: True, node: 1048, tag: header, level: 13" node_number="1048"><h2 class="valid" valid="valid" title="valid: True, node: 1049, tag: h2, level: 14" node_number="1049">Metrics Citations</h2></header><section class="valid" valid="valid" title="valid: True, node: 1050, tag: section, level: 13" node_number="1050"><h3 class="valid" valid="valid" title="valid: True, node: 1051, tag: h3, level: 14" node_number="1051">Metrics</h3><section class="valid" valid="valid" title="valid: True, node: 1052, tag: section, level: 14" node_number="1052"> <h5 title="valid: False, node: 1053, tag: h5, level: 15" node_number="1053"> Article Usage </h5> </section><section class="valid" valid="valid" title="valid: True, node: 1054, tag: section, level: 14" node_number="1054"> <h5 title="valid: False, node: 1055, tag: h5, level: 15" node_number="1055"> Altmetrics </h5> </section></section><section class="valid" valid="valid" title="valid: True, node: 1056, tag: section, level: 13" node_number="1056"><h3 class="valid" valid="valid" title="valid: True, node: 1057, tag: h3, level: 14" node_number="1057">Citations</h3><section class="valid" valid="valid" title="valid: True, node: 1058, tag: section, level: 14" node_number="1058"> <div title="valid: False, node: 1059, tag: div, level: 15" node_number="1059"> <h5 title="valid: False, node: 1060, tag: h5, level: 16" node_number="1060">Export citation</h5> <p title="valid: False, node: 1061, tag: p, level: 16" node_number="1061">Select the format you want to export the citation of this publication.</p> </div> </section></section></div><div class="valid" valid="valid" title="valid: True, node: 1062, tag: div, level: 12" node_number="1062"><header class="valid" valid="valid" title="valid: True, node: 1063, tag: header, level: 13" node_number="1063"><h2 class="valid" valid="valid" title="valid: True, node: 1064, tag: h2, level: 14" node_number="1064">View Options</h2></header><div class="valid" valid="valid" title="valid: True, node: 1065, tag: div, level: 13" node_number="1065"><h3 class="valid" valid="valid" title="valid: True, node: 1066, tag: h3, level: 14" node_number="1066">Get Access</h3><section class="valid" valid="valid" title="valid: True, node: 1067, tag: section, level: 14" node_number="1067"> <div title="valid: False, node: 1068, tag: div, level: 15" node_number="1068"><h5 title="valid: False, node: 1069, tag: h5, level: 16" node_number="1069">Log in to view the full text</h5> <p title="valid: False, node: 1070, tag: p, level: 16" node_number="1070"><a title="valid: False, node: 1071, tag: a, level: 17" node_number="1071">AAAS Log in</a></p> <p title="valid: False, node: 1072, tag: p, level: 16" node_number="1072">AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul title="valid: False, node: 1073, tag: ul, level: 16" node_number="1073"> <li title="valid: False, node: 1074, tag: li, level: 17" node_number="1074">Become a AAAS Member</li> <li title="valid: False, node: 1075, tag: li, level: 17" node_number="1075"><a title="valid: False, node: 1076, tag: a, level: 18" node_number="1076">Activate your Account</a></li> <li title="valid: False, node: 1077, tag: li, level: 17" node_number="1077"><a title="valid: False, node: 1078, tag: a, level: 18" node_number="1078">Purchase Access to Other Journals in the Science Family</a></li> <li title="valid: False, node: 1079, tag: li, level: 17" node_number="1079"><a title="valid: False, node: 1080, tag: a, level: 18" node_number="1080">Account Help</a></li> </ul> <div title="valid: False, node: 1081, tag: div, level: 16" node_number="1081"> <div title="valid: False, node: 1082, tag: div, level: 17" node_number="1082">Log in via OpenAthens. <div title="valid: False, node: 1083, tag: div, level: 18" node_number="1083"><a title="valid: False, node: 1084, tag: a, level: 19" node_number="1084">via OpenAthens</a></div> </div> <div title="valid: False, node: 1085, tag: div, level: 17" node_number="1085">Log in via Shibboleth. <div title="valid: False, node: 1086, tag: div, level: 18" node_number="1086"><a title="valid: False, node: 1087, tag: a, level: 19" node_number="1087">via Shibboleth</a></div> </div> </div> </div> <div title="valid: False, node: 1088, tag: div, level: 15" node_number="1088"><h4 title="valid: False, node: 1089, tag: h4, level: 16" node_number="1089">More options</h4><p title="valid: False, node: 1090, tag: p, level: 16" node_number="1090"><a title="valid: False, node: 1091, tag: a, level: 17" node_number="1091">Purchase digital access to this article</a></p><p title="valid: False, node: 1092, tag: p, level: 16" node_number="1092">Download and print this article for your personal scholarly, research, and educational use.</p></div> </section></div><div class="valid" valid="valid" title="valid: True, node: 1093, tag: div, level: 13" node_number="1093"><h3 class="valid" valid="valid" title="valid: True, node: 1094, tag: h3, level: 14" node_number="1094">View options</h3><section class="valid" valid="valid" title="valid: True, node: 1095, tag: section, level: 14" node_number="1095"><h4 title="valid: False, node: 1096, tag: h4, level: 15" node_number="1096">PDF format</h4><p title="valid: False, node: 1097, tag: p, level: 15" node_number="1097">Download this article as a PDF file</p><a title="valid: False, node: 1098, tag: a, level: 15" node_number="1098">Download PDF</a></section></div></div><div class="valid" valid="valid" title="valid: True, node: 1099, tag: div, level: 12" node_number="1099"><header class="valid" valid="valid" title="valid: True, node: 1100, tag: header, level: 13" node_number="1100"><h2 class="valid" valid="valid" title="valid: True, node: 1101, tag: h2, level: 14" node_number="1101">Media</h2></header><section class="valid" valid="valid" title="valid: True, node: 1102, tag: section, level: 13" node_number="1102"><h3 class="valid" valid="valid" title="valid: True, node: 1103, tag: h3, level: 14" node_number="1103">Figures</h3></section><section class="valid" valid="valid" title="valid: True, node: 1104, tag: section, level: 13" node_number="1104"><h3 class="valid" valid="valid" title="valid: True, node: 1105, tag: h3, level: 14" node_number="1105">Multimedia</h3></section></div><div class="valid" valid="valid" title="valid: True, node: 1106, tag: div, level: 12" node_number="1106"><header class="valid" valid="valid" title="valid: True, node: 1107, tag: header, level: 13" node_number="1107"><h2 class="valid" valid="valid" title="valid: True, node: 1108, tag: h2, level: 14" node_number="1108">Tables</h2></header></div><div class="valid" valid="valid" title="valid: True, node: 1109, tag: div, level: 12" node_number="1109"><header class="valid" valid="valid" title="valid: True, node: 1110, tag: header, level: 13" node_number="1110"><h2 class="valid" valid="valid" title="valid: True, node: 1111, tag: h2, level: 14" node_number="1111">Share</h2></header><h3 class="valid" valid="valid" title="valid: True, node: 1112, tag: h3, level: 13" node_number="1112">Share</h3><div class="valid" valid="valid" title="valid: True, node: 1113, tag: div, level: 13" node_number="1113"><section class="valid" valid="valid" title="valid: True, node: 1114, tag: section, level: 14" node_number="1114"><h4 title="valid: False, node: 1115, tag: h4, level: 15" node_number="1115">Share article link</h4><div title="valid: False, node: 1116, tag: div, level: 15" node_number="1116"><a title="valid: False, node: 1117, tag: a, level: 16" node_number="1117">Copy Link</a><div title="valid: False, node: 1118, tag: div, level: 16" node_number="1118"><p title="valid: False, node: 1119, tag: p, level: 17" node_number="1119">Copied!</p><p title="valid: False, node: 1120, tag: p, level: 17" node_number="1120">Copying failed.</p></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1121, tag: section, level: 14" node_number="1121"><h4 title="valid: False, node: 1122, tag: h4, level: 15" node_number="1122">Share on social media</h4><div title="valid: False, node: 1123, tag: div, level: 15" node_number="1123"><a title="valid: False, node: 1124, tag: a, level: 16" node_number="1124">facebook</a><a title="valid: False, node: 1125, tag: a, level: 16" node_number="1125">twitter</a><a title="valid: False, node: 1126, tag: a, level: 16" node_number="1126">linkedin</a><a title="valid: False, node: 1127, tag: a, level: 16" node_number="1127">email</a></div></section></div></div></div></article><section class="valid" valid="valid" title="valid: True, node: 1128, tag: section, level: 10" node_number="1128"><div class="valid" valid="valid" title="valid: True, node: 1129, tag: div, level: 11" node_number="1129"><div class="valid" valid="valid" title="valid: True, node: 1130, tag: div, level: 12" node_number="1130"><div class="valid" valid="valid" title="valid: True, node: 1131, tag: div, level: 13" node_number="1131"><div class="valid" valid="valid" title="valid: True, node: 1132, tag: div, level: 14" node_number="1132"><h3 title="valid: False, node: 1133, tag: h3, level: 15" node_number="1133">Submit a Response to This Article</h3></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 1134, tag: div, level: 11" node_number="1134"> <div class="valid" valid="valid" title="valid: True, node: 1135, tag: div, level: 12" node_number="1135"> <h2 class="valid" valid="valid" title="valid: True, node: 1136, tag: h2, level: 13" node_number="1136">(0)eLetters</h2> </div> <p class="valid" valid="valid" title="valid: True, node: 1137, tag: p, level: 12" node_number="1137">eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> Log In to Submit a Response <p class="valid" valid="valid" title="valid: True, node: 1138, tag: p, level: 12" node_number="1138">No eLetters have been published for this article yet.</p> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 1139, tag: div, level: 10" node_number="1139"><a class="valid" valid="valid" title="valid: True, node: 1140, tag: a, level: 11" node_number="1140">View Full Text</a><a class="valid" valid="valid" title="valid: True, node: 1141, tag: a, level: 11" node_number="1141">Download PDF</a></div> </div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1142, tag: div, level: 6" node_number="1142"><div class="valid" valid="valid" title="valid: True, node: 1143, tag: div, level: 7" node_number="1143"><div class="valid" valid="valid" title="valid: True, node: 1144, tag: div, level: 8" node_number="1144"><div class="valid" valid="valid" title="valid: True, node: 1145, tag: div, level: 9" node_number="1145"><section class="valid" valid="valid" title="valid: True, node: 1146, tag: section, level: 10" node_number="1146"><div class="valid" valid="valid" title="valid: True, node: 1147, tag: div, level: 11" node_number="1147"><h4 class="valid" valid="valid" title="valid: True, node: 1148, tag: h4, level: 12" node_number="1148"> Current Issue </h4><div class="valid" valid="valid" title="valid: True, node: 1149, tag: div, level: 12" node_number="1149"><div class="valid" valid="valid" title="valid: True, node: 1150, tag: div, level: 13" node_number="1150"> <div class="valid" valid="valid" title="valid: True, node: 1151, tag: div, level: 14" node_number="1151"><div title="valid: False, node: 1152, tag: div, level: 15" node_number="1152"><article title="valid: False, node: 1153, tag: article, level: 16" node_number="1153"><div title="valid: False, node: 1154, tag: div, level: 17" node_number="1154"><div title="valid: False, node: 1155, tag: div, level: 18" node_number="1155"><h3 title="valid: False, node: 1156, tag: h3, level: 19" node_number="1156"><a title="valid: False, node: 1157, tag: a, level: 20" node_number="1157">Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics</a></h3><ul title="valid: False, node: 1158, tag: ul, level: 19" node_number="1158"><li title="valid: False, node: 1159, tag: li, level: 20" node_number="1159">By<ul title="valid: False, node: 1160, tag: ul, level: 21" node_number="1160"> <li title="valid: False, node: 1161, tag: li, level: 22" node_number="1161">Jay-Hyun Jo</li> <li title="valid: False, node: 1162, tag: li, level: 22" node_number="1162">Catriona P. Harkins</li> <li title="valid: False, node: 1163, tag: li, level: 22" node_number="1163">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 1164, tag: article, level: 16" node_number="1164"><div title="valid: False, node: 1165, tag: div, level: 17" node_number="1165"><div title="valid: False, node: 1166, tag: div, level: 18" node_number="1166"><h3 title="valid: False, node: 1167, tag: h3, level: 19" node_number="1167">A human orthogonal IL-2 and IL-2R&#946; system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</h3><ul title="valid: False, node: 1168, tag: ul, level: 19" node_number="1168"><li title="valid: False, node: 1169, tag: li, level: 20" node_number="1169">By<ul title="valid: False, node: 1170, tag: ul, level: 21" node_number="1170"> <li title="valid: False, node: 1171, tag: li, level: 22" node_number="1171">Qian Zhang</li> <li title="valid: False, node: 1172, tag: li, level: 22" node_number="1172">Morgan E. Hresko</li> <li title="valid: False, node: 1173, tag: li, level: 22" node_number="1173">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 1174, tag: article, level: 16" node_number="1174"><div title="valid: False, node: 1175, tag: div, level: 17" node_number="1175"><div title="valid: False, node: 1176, tag: div, level: 18" node_number="1176"><h3 title="valid: False, node: 1177, tag: h3, level: 19" node_number="1177">An orthogonal IL-2 and IL-2R&#946; system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h3><ul title="valid: False, node: 1178, tag: ul, level: 19" node_number="1178"><li title="valid: False, node: 1179, tag: li, level: 20" node_number="1179">By<ul title="valid: False, node: 1180, tag: ul, level: 21" node_number="1180"> <li title="valid: False, node: 1181, tag: li, level: 22" node_number="1181">Paul-Joseph Aspuria</li> <li title="valid: False, node: 1182, tag: li, level: 22" node_number="1182">Sandro Vivona</li> <li title="valid: False, node: 1183, tag: li, level: 22" node_number="1183">et al.</li> </ul> </li></ul></div></div></article></div><div title="valid: False, node: 1184, tag: div, level: 15" node_number="1184">Table of Contents</div></div> </div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1185, tag: section, level: 10" node_number="1185"> <h4 class="valid" valid="valid" title="valid: True, node: 1186, tag: h4, level: 11" node_number="1186">LATEST NEWS</h4> <div class="valid" valid="valid" title="valid: True, node: 1187, tag: div, level: 11" node_number="1187"> <div class="valid" valid="valid" title="valid: True, node: 1188, tag: div, level: 12" node_number="1188"><div class="valid" valid="valid" title="valid: True, node: 1189, tag: div, level: 13" node_number="1189"> <article class="valid" valid="valid" title="valid: True, node: 1190, tag: article, level: 14" node_number="1190"> <div title="valid: False, node: 1191, tag: div, level: 15" node_number="1191"> <div title="valid: False, node: 1192, tag: div, level: 16" node_number="1192"> News<time title="valid: False, node: 1193, tag: time, level: 17" node_number="1193">30 Dec 2021</time> </div> <div title="valid: False, node: 1194, tag: div, level: 16" node_number="1194"> Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1195, tag: article, level: 14" node_number="1195"> <div title="valid: False, node: 1196, tag: div, level: 15" node_number="1196"> <div title="valid: False, node: 1197, tag: div, level: 16" node_number="1197"> ScienceInsider<time title="valid: False, node: 1198, tag: time, level: 17" node_number="1198">29 Dec 2021</time> </div> <div title="valid: False, node: 1199, tag: div, level: 16" node_number="1199"> <a title="valid: False, node: 1200, tag: a, level: 17" node_number="1200"> Once a &#8216;crazy idea,&#8217; patent-pooling nonprofit will help bring COVID-19 pills to world&#8217;s poor </a> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1201, tag: article, level: 14" node_number="1201"> <div title="valid: False, node: 1202, tag: div, level: 15" node_number="1202"> <div title="valid: False, node: 1203, tag: div, level: 16" node_number="1203"> ScienceInsider<time title="valid: False, node: 1204, tag: time, level: 17" node_number="1204">28 Dec 2021</time> </div> <div title="valid: False, node: 1205, tag: div, level: 16" node_number="1205"> The natural world loses two of its biggest advocates </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1206, tag: article, level: 14" node_number="1206"> <div title="valid: False, node: 1207, tag: div, level: 15" node_number="1207"> <div title="valid: False, node: 1208, tag: div, level: 16" node_number="1208"> ScienceInsider<time title="valid: False, node: 1209, tag: time, level: 17" node_number="1209">28 Dec 2021</time> </div> <div title="valid: False, node: 1210, tag: div, level: 16" node_number="1210"> <a title="valid: False, node: 1211, tag: a, level: 17" node_number="1211"> What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1212, tag: article, level: 14" node_number="1212"> <div title="valid: False, node: 1213, tag: div, level: 15" node_number="1213"> <div title="valid: False, node: 1214, tag: div, level: 16" node_number="1214"> ScienceInsider<time title="valid: False, node: 1215, tag: time, level: 17" node_number="1215">25 Dec 2021</time> </div> <div title="valid: False, node: 1216, tag: div, level: 16" node_number="1216"> NASA&#8217;s Webb telescope takes flight&#8212;a Christmas gift to astronomers everywhere </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1217, tag: article, level: 14" node_number="1217"> <div title="valid: False, node: 1218, tag: div, level: 15" node_number="1218"> <div title="valid: False, node: 1219, tag: div, level: 16" node_number="1219"> News<time title="valid: False, node: 1220, tag: time, level: 17" node_number="1220">23 Dec 2021</time> </div> <div title="valid: False, node: 1221, tag: div, level: 16" node_number="1221"> <a title="valid: False, node: 1222, tag: a, level: 17" node_number="1222"> More than a virus: Science&#8217;s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>